Downloads: 1
Diff of
/clusters/3009knumclusters/clust_60.txt
[000000]
..
[c09aa8]
Switch to unified view
| a | b/clusters/3009knumclusters/clust_60.txt | ||
|---|---|---|---|
| 1 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 60%) and life expectancy greater than 6 months; furthermore, enrollment of patients with greater than 10 measurable lesions is discouraged |
||
| 2 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky or Lansky >= 70%) |
||
| 3 | Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status of 0 or 1 (Karnofsky >= 70%) |
||
| 4 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 5 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 6 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 7 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 for Part 1 and ? 1 for Part 2. Adequate organ function. |
||
| 8 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 80%) |
||
| 9 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 10 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 and minimum life expectancy of 4 weeks |
||
| 11 | Karnofsky performance status > 70 or Eastern Cooperative Oncology Group (ECOG) ? |
||
| 12 | Must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 13 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 14 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 15 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1 (Karnofsky >= 60%) |
||
| 16 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 17 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 18 | An Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1. |
||
| 19 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 20 | Eastern Cooperative Oncology Group (ECOG) Performance status of ? 1 |
||
| 21 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1. |
||
| 22 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 23 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 24 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 25 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =< 1 and a life expectancy of at least 3 months |
||
| 26 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 27 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-1 |
||
| 28 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 29 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 within 2 weeks prior to screening |
||
| 30 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 31 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 32 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 33 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 34 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 35 | The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 36 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 37 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 38 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1\r\n* NOTE: Participants with impaired decision-making capacity (IDMC) should not be allowed to participate in this study due to its complexity |
||
| 39 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 40 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 41 | Patient has Eastern Cooperative Oncology Group (ECOG) performance status 0-1 within 2 weeks prior to randomization |
||
| 42 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 43 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 44 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 45 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 46 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 47 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 90 days prior to step 1 registration |
||
| 48 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 49 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 50 | Patients have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 51 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 52 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 53 | Eastern Cooperative Oncology Group (ECOG) performance status must be =< 2 |
||
| 54 | Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2 |
||
| 55 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 60 days prior to registration |
||
| 56 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 57 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 58 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 59 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 60 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 61 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 62 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 63 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%) |
||
| 64 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 65 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 66 | Participants must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1 |
||
| 67 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 68 | Performance status ? 2 [Eastern Cooperative Oncology Group (ECOG)] |
||
| 69 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 70 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 71 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 72 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 73 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 74 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 75 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 76 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 77 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 1. |
||
| 78 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 79 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 80 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 81 | Eastern Cooperative Oncology Group (ECOG) Performance Status <=2. |
||
| 82 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 83 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 84 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 - 1. |
||
| 85 | Eastern Cooperative Oncology Group performance status of 0-1 |
||
| 86 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%) |
||
| 87 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 88 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 89 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 90 | Eastern Cooperative Oncology Group (ECOG) status 0-2 within 1 month prior to registration |
||
| 91 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 within 7 days of enrollment |
||
| 92 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 93 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 94 | Eastern Cooperative Oncology Group (ECOG) performance status of zero to two unless decline is due to bony disease |
||
| 95 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 96 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 97 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 98 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance score =< 3 (Karnofsky >= 30) |
||
| 99 | ELIGIBILITY CRITERIA - PHASE I (ARMS A, B, C): Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 100 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 101 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 102 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 103 | Patients must have Eastern Cooperative Oncology Group (ECOG) Performance Status ? 1. |
||
| 104 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 105 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 106 | Eastern Cooperative Oncology Group (ECOG) performance status ? 3 for subjects aged > 16 years; Lansky score ? 20 for subjects from birth to 16 years |
||
| 107 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 108 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 109 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky >= 60%) |
||
| 110 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 111 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 112 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 113 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 114 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 115 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 116 | Eastern Cooperative Oncology Group (ECOG) performance status <= 2. |
||
| 117 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 118 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 119 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0, 1, or 2 |
||
| 120 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 121 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 14 days prior to registration |
||
| 122 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 within 10 days prior to the start of study treatment. |
||
| 123 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1; |
||
| 124 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 125 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 126 | Eastern Co-Operative Group (Eastern Cooperative Oncology Group [ECOG]) performance score of 0 or 1 |
||
| 127 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 128 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 129 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale up to 14 days before treatment initiation |
||
| 130 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 131 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 132 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 133 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 134 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 135 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 136 | Subject has Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1. |
||
| 137 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 138 | Participant has Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 139 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 140 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 141 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 142 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 143 | Performance status 0-1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 144 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 145 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 146 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 147 | ECOG (Eastern cooperative oncology group) performance status ?2 |
||
| 148 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 149 | Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 2 |
||
| 150 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 1 at screening. |
||
| 151 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 152 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 153 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 154 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 155 | Eastern Cooperative Oncology Group performance status of ?3; |
||
| 156 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 1. |
||
| 157 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 158 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 159 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 160 | Participant has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1. |
||
| 161 | Patients must be ambulatory with good performance status (Eastern Cooperative Oncology Group [ECOG] 0 or 1) |
||
| 162 | INCLUSION CRITERIA FOR SECOND-LINE THERAPY: Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 163 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 164 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 165 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 166 | ECOG (Eastern Cooperative Oncology Group) performance status 0-2 |
||
| 167 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 168 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 169 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG), performance status of 0-1 =< 14 days prior to registration |
||
| 170 | Eastern Cooperative Oncology Group (ECOG): 0 to 2 |
||
| 171 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60) |
||
| 172 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 173 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 174 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 175 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 176 | Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; |
||
| 177 | Subject has an Eastern Cooperative Oncology Group performance score (ECOG) ? 2 |
||
| 178 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 179 | COHORT 1: Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 180 | Eastern Cooperative Oncology Group (ECOG) performance status must be ?2 (Appendix A). |
||
| 181 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 182 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 183 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 184 | Karnofsky performance status of 70-100%; Eastern Cooperative Oncology Group (ECOG) performance status =< [2] |
||
| 185 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 186 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 187 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 188 | Have a performance status of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 189 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 190 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 191 | Karnofsky performance status >= 60% or Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 192 | SAFETY RUN-IN: Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 193 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 and Life expectancy of at least 12 weeks |
||
| 194 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 195 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 196 | Patients with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 197 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 198 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 199 | Eastern Cooperative Oncology Group performance status of =< 1 |
||
| 200 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 201 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 202 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 203 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1 |
||
| 204 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 205 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 206 | Participant must have Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 207 | Eastern cooperative oncology group (ECOG) performed status of 0, 1 or 2; 0 or 1 (cohort E only) |
||
| 208 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 209 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 210 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 211 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 212 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 213 | Performance Status: Eastern Cooperative Oncology Group (ECOG) 0-1. |
||
| 214 | Must have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2. |
||
| 215 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 216 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 217 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 218 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 219 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 220 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 221 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 222 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 223 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 224 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 225 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 226 | Eastern Cooperative Group (ECOG) performance scale 0-1 |
||
| 227 | Must have an Eastern Cooperative Oncology Group (ECOG) performance status score 0, 1, or 2 |
||
| 228 | Subject has an Eastern Cooperative Oncology Group (ECOG) =< 2 performance status OR Karnofsky >= 60% performance status |
||
| 229 | Eastern Cooperative Oncology Group (ECOG) =< 3 |
||
| 230 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 231 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 232 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 233 | Eastern Cooperative Oncology Group performance status of 0 to 2 |
||
| 234 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 235 | Eastern Collaborative Oncology Group (ECOG) Performance Status of 0-1 (Appendix 1). |
||
| 236 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 237 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 238 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 239 | Good performance status (Eastern Cooperative Oncology Group [ECOG] 0 or 1; Karnofsky and Lansky 70-100) |
||
| 240 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1. |
||
| 241 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 242 | Karnofsky performance status >= 50% or Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 243 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 244 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 245 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 246 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 247 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 248 | Eastern Cooperative Oncology Group (ECOG) performance status < 3 |
||
| 249 | Have a performance status of ?1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 250 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 251 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 252 | Gynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky scale (KPS) =< 70% |
||
| 253 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 254 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 255 | Has an Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 256 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 257 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 258 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 259 | Performance status score of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 260 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 261 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 262 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 263 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 264 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 265 | Patients who must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 266 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 267 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 268 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 (Karnofsky >= 60%) |
||
| 269 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 or Lansky performance status of >= 30 |
||
| 270 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 271 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 272 | An Eastern Cooperative Oncology Group (ECOG) performance score 0-2 |
||
| 273 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 274 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 275 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 276 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1. |
||
| 277 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 278 | Eastern Cooperative Oncology Group Performance Status (ECOG) status of 0 or 1 |
||
| 279 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 280 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 281 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 within 10 days of randomization. |
||
| 282 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 283 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 (Karnofsky ? 60%) |
||
| 284 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 285 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 286 | Eastern Cooperative Oncology Group (ECOG) Performance Status grade of 0, 1, or 2 |
||
| 287 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 288 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 10 days of study start |
||
| 289 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 290 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 291 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 292 | Eastern Cooperative Oncology Group (ECOG) performance status of ?1 |
||
| 293 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 294 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 295 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 296 | Must have an Eastern Cooperative Oncology Group (ECOG) Performance status of: |
||
| 297 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 298 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 299 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 300 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 301 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 302 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 303 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky >= 70%) |
||
| 304 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 305 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 306 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 307 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 308 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 309 | Participants >= 16 years Eastern Cooperative Oncology Group (ECOG) 0 or 1/Karnofsky performance status (KPS) 100-70% |
||
| 310 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 311 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 312 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 313 | Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2. |
||
| 314 | Eastern Cooperative Oncology Group Performance Status of 0 to 1. |
||
| 315 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 316 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 317 | Patients must exhibit a/an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 318 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 319 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 320 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 321 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 322 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 323 | ENROLLMENT TO THE DOSE ESCALATION, EXPANSION AND PART II: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 324 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 325 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 326 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 327 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 328 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 329 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 330 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 331 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 332 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 333 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 334 | Eastern Cooperative Oncology Group (ECOG) status =< 2 |
||
| 335 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 336 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 337 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1 |
||
| 338 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 339 | Must have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 340 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 341 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 342 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 343 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 344 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 345 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 346 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 347 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 348 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 or Karnofsky performance status (KPS) 100 to 70 |
||
| 349 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 350 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 351 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 352 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2. |
||
| 353 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 354 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 355 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 356 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky > 50% (if >= 16 years of age); or children < 16 years old must have a Lansky performance of >= 50% |
||
| 357 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 358 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 359 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 360 | Has an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1. |
||
| 361 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 362 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 within 28 days prior to study registration. |
||
| 363 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 (asymptomatic to symptomatic but capable of self-care) within 45 days prior to randomization |
||
| 364 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 365 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 366 | Eastern Cooperative Oncology Group performance status of less than or equal to (</=) 2 |
||
| 367 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 368 | Eastern Cooperative Oncology Group (ECOG) Performance Status grade 0 or 1 |
||
| 369 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 1 and adequate organ function |
||
| 370 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 371 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 372 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 373 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 374 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 375 | Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status of 0, 1, or 2 within 28 days prior to registration |
||
| 376 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 3 days prior to first dose of pembrolizumab |
||
| 377 | Eastern Cooperative Oncology Group (ECOG) performance status >= 3 |
||
| 378 | Eastern Cooperate Oncology Group (ECOG) performance status =< 2 |
||
| 379 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 as documented within 3 months prior to study entry |
||
| 380 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 381 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 382 | Eastern Collaborative Oncology Group (ECOG) performance status of 0 or 1 at screening |
||
| 383 | The participant has an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 384 | Eastern Cooperative Oncology Group performance status and/or other performance status of ? 1. |
||
| 385 | Patients must demonstrate an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 386 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 387 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 388 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 389 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 2 |
||
| 390 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 1, measured within 72 hours before the start of treatment. |
||
| 391 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 392 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 393 | Eastern Collaborative Oncology Group (ECOG) Performance Status of ?2 |
||
| 394 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 395 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 396 | Eastern Cooperative Oncology Group (ECOG) performance status = 0 or 1 |
||
| 397 | Eastern Cooperative Oncology Group performance status less than or equal to 2 |
||
| 398 | Have an Eastern Cooperative Oncology Group [ECOG] performance status 0 or 1 |
||
| 399 | Eastern Cooperative Oncology Group Performance (ECOG) Status of 0 or 1 |
||
| 400 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 401 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky >= 70% |
||
| 402 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 403 | Eastern Cooperative Oncology Group (ECOG) performance status < 2. |
||
| 404 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 405 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 406 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 407 | Eastern Cooperative Oncology Group (ECOG) performance status assessment of 0 or 1 |
||
| 408 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 409 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 410 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 411 | Eastern Cooperative Group (ECOG) performance status is 0-2 at Screening. |
||
| 412 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 413 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status. |
||
| 414 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 415 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 416 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 417 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 418 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 419 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 420 | Performance status 0 or 1 on Eastern Cooperative Oncology Group Performance Scale. |
||
| 421 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 422 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 with no clinical deterioration over the previous 2 weeks and likely able to complete at least 9 weeks of treatment. |
||
| 423 | Eastern Cooperative Oncology Group (ECOG) performance status = 0 or 1 or Karnofsky performance status equivalent |
||
| 424 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 425 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 426 | Have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 427 | ECOG (Eastern Cooperative Oncology Group) performance status ?1 |
||
| 428 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 429 | Eastern Cooperative Oncology Group score of 0 or 1. |
||
| 430 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky performance status >= 60) |
||
| 431 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Appendix A) |
||
| 432 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 433 | The patient has an Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 434 | Performance status 0 or 1 on Eastern Cooperative Oncology Group Performance Scale. |
||
| 435 | Must have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2. |
||
| 436 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 437 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 438 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 439 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 440 | Eastern Cooperative Oncology Group performance status =< 1 |
||
| 441 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 442 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 443 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0–2 |
||
| 444 | Karnofsky or Lansky performance status of >= 60% or Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 445 | Eastern Cooperative Oncology Group performance status 0, 1, or 2 |
||
| 446 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 447 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 448 | Eastern Cooperative Oncology Group (ECOG) score ? 2 |
||
| 449 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 450 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 451 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-1 |
||
| 452 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 453 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 454 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 455 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 456 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 457 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 458 | Screening Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 459 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 460 | Eastern Cooperative Oncology Group (ECOG) ? 2 |
||
| 461 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 462 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 |
||
| 463 | European Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 464 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 465 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 466 | Eastern Cooperative Oncology Group (ECOG) of 0 to 1 |
||
| 467 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 within 30 days prior to registration |
||
| 468 | Performance status: Eastern Cooperative Oncology Group (ECOG) 0-1 and life expectancy >= 1 year |
||
| 469 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2. |
||
| 470 | Eastern Cooperative Oncology Group Performance Status 0-1 |
||
| 471 | Study subject must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 472 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 473 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 474 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 475 | Eastern Cooperative Oncology Group Performance Status of 0 to 2. |
||
| 476 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 477 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 478 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 and minimum life expectancy of ? 3 months |
||
| 479 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 480 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 481 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 482 | Eastern Cooperative Oncology Group performance status of 0 to 1. |
||
| 483 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0-2 |
||
| 484 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2 |
||
| 485 | Performance status (Eastern Cooperative Oncology Group [ECOG] 0-1) |
||
| 486 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 487 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 488 | Eastern Cooperative Oncology Group (ECOG) 0 or 1. |
||
| 489 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 490 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 491 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 492 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 493 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 494 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) is required for eligibility; those patients with lower performance status based solely on bone pain secondary to multiple myeloma are eligible |
||
| 495 | Eastern Cooperative Oncology Group (ECOG) performance status of 0–2 |
||
| 496 | Patient has a Karnofsky performance status score of >= 70 or Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 497 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 498 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 499 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 500 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2; performance status of 3 will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiated |
||
| 501 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 502 | Karnofsky performance status >= 60 (Eastern Cooperative Oncology Group [ECOG] 0-1) |
||
| 503 | Eastern Cooperative Oncology Group (ECOG) performance status 0–4 |
||
| 504 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 505 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2 |
||
| 506 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 507 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 - 2 |
||
| 508 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 509 | Eastern Cooperative Oncology Group (ECOG) performance status of <=1. |
||
| 510 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 511 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 512 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Phase I), =< 1 (Phase II) |
||
| 513 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 at study entry |
||
| 514 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 515 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 516 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 517 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 518 | ECOG (Eastern Cooperative Oncology Group) performance score of 1 or 0. Subjects in the Phase 2 portion: ECOG performance score of 2, 1, or 0. |
||
| 519 | Eastern Cooperative Oncology Group (ECOG) performance 0-3 |
||
| 520 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky > 60%) |
||
| 521 | Eastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]) performance status 0 or 1 or 2 |
||
| 522 | PART I: Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 523 | Karnofsky performance score >= 70% or Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 524 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 525 | Have an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 526 | Have a performance status of at least 1 on the Eastern Cooperative Oncology Group (ECOG) scale and life expectancy >6 months |
||
| 527 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 528 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 529 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 530 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 531 | ECOG (Eastern Cooperative Oncology Group) performance status 0 to 2 |
||
| 532 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 at study entry |
||
| 533 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 534 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 535 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 536 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 537 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 538 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 539 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 within 14 days prior to being registered for protocol therapy |
||
| 540 | Eastern Cooperative Oncology Group (ECOG) performance 0-4 |
||
| 541 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 542 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale. |
||
| 543 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 544 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 545 | Eastern Cooperative Oncology Group (ECOG) 0- 1 |
||
| 546 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 assessed within 90 days of enrollment |
||
| 547 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 548 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 549 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry. |
||
| 550 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 551 | Eastern cooperative oncology group (ECOG) performance status ? 1 and life expectancy > 12 weeks |
||
| 552 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 553 | Participant must have Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 554 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 555 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1. |
||
| 556 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 557 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%). |
||
| 558 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 559 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 560 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1. |
||
| 561 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 562 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 563 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 to 2 |
||
| 564 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 565 | Performance status ? 3 (Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 566 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 567 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 568 | Eastern Cooperative Oncology Group (ECOG) performance status ?2. |
||
| 569 | Eastern Cooperative Oncology Group (ECOG) performance score of 2 or better. |
||
| 570 | Have a performance status of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) Performance Scale; |
||
| 571 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 572 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 573 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 574 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 575 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. Evaluation of ECOG is to be performed within 7 days prior to the date of allocation/randomization |
||
| 576 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 (Karnofsky ? 60%) |
||
| 577 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1. |
||
| 578 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 579 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-2. |
||
| 580 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 581 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, or 1 |
||
| 582 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 583 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2. |
||
| 584 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 585 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance score of =< 2 |
||
| 586 | Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 587 | Eastern Cooperative Oncology Group (ECOG) of 4 and life expectancy ? 2 weeks |
||
| 588 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 589 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 590 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 591 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 592 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 593 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 594 | Eastern Cooperative Group (ECOG) performance status =< 1 |
||
| 595 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1 |
||
| 596 | Performance status (Eastern Cooperative Oncology Group [EGOG] 0-1) |
||
| 597 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 598 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better |
||
| 599 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 600 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 601 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 602 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 at enrollment and within 7 days of initiating lymphodepleting chemotherapy. |
||
| 603 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 14 days prior to registration. Cisplatin-ineligible chemotherapy-naive subjects may have an ECOG performance status of =< 2. |
||
| 604 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 605 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 606 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 607 | an Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2. |
||
| 608 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 609 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 at enrollment |
||
| 610 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 at Screening. |
||
| 611 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 612 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 613 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 614 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2. |
||
| 615 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 616 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 617 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 618 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status =< 1. |
||
| 619 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 620 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky >=70%). |
||
| 621 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 622 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 623 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 624 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 625 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 626 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 627 | Eastern Cooperative Oncology Group performance status 0-1 at time of informed consent |
||
| 628 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 629 | World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG)-performance status 0-2 |
||
| 630 | An Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 and a minimum life expectancy of 12 weeks |
||
| 631 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 632 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 633 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and estimated life expectancy of ? 3 months |
||
| 634 | Adequate performance status: Eastern Cooperative Oncology Group (ECOG) 0 or 1/Karnofsky performance status (KPS) 100-70% |
||
| 635 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 636 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 637 | For cohorts 1-3, clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 638 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 639 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 640 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 641 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 642 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 643 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 644 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 645 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 646 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 647 | Eastern Cooperative Oncology Group (ECOG) performance status ? 3 |
||
| 648 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 649 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 650 | Has an Eastern Cooperative Oncology Group performance status 0-1 |
||
| 651 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 652 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 653 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 654 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 655 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 656 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale. |
||
| 657 | STUDY TREATMENT: Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2. |
||
| 658 | COHORT 1: HORMONE RECEPTOR POSITIVE BREAST CANCER: Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 659 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 660 | Performance status of 0 or 1 if using Eastern Cooperative Oncology Group (ECOG)/Zubrod. |
||
| 661 | Eastern Cooperative Oncology Group (ECOG) performance status Grade 0, 1, or 2 |
||
| 662 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2. |
||
| 663 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 664 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky or Lansky >= 70%) |
||
| 665 | Eastern Cooperative Oncology Group (ECOG) performance status =<1 (Karnofsky >= 60%) |
||
| 666 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 667 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 668 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 669 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 670 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 671 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 672 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 673 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 674 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 675 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 676 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 677 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 678 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 679 | Eastern Cooperative Oncology Group [ECOG] performance must be 0 or 1. |
||
| 680 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 681 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 682 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 683 | Karnofsky performance status (KPS) of >= 70% or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 684 | Eastern Cooperative Group ECOG) Performance Status score of 0 or 1. |
||
| 685 | Have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 686 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 687 | Eastern Cooperative Oncology Group (ECOG) performance status >= 2 |
||
| 688 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 689 | Eastern Cooperative Oncology Group performance status of ? 2 |
||
| 690 | Performance status Eastern Cooperative Oncology Group (ECOG) performance status 0- =< 2 |
||
| 691 | Eastern Cooperative Oncology Group (ECOG) performance status score (0 and 1) |
||
| 692 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-2 |
||
| 693 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 694 | Eastern Cooperative Oncology Group performance status 0-1 |
||
| 695 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 696 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 697 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 698 | Performance status 0-1 (by Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 699 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 700 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 701 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 702 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 703 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 704 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at screening |
||
| 705 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-1 |
||
| 706 | Eastern Cooperative Oncology Group (ECOG) performance status 0 -1 |
||
| 707 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 708 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 709 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 710 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 711 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 (0, 1 or 2) |
||
| 712 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 713 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 714 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale or > 70% on the Karnofsky scale |
||
| 715 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-2 |
||
| 716 | Eastern Cooperative Oncology Group (ECOG) performance Status of 0 or 1 |
||
| 717 | Eastern Cooperative Oncology Group (ECOG) performance score 0 or 1 |
||
| 718 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0-2 |
||
| 719 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2. |
||
| 720 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 721 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 722 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 723 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 724 | ECOG (Eastern Cooperative Oncology Group) performance status score of 0 – 2 |
||
| 725 | Eastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]/Gynecologic Oncology Group [GOG]/Zubrod score) performance status 0 - 2 |
||
| 726 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale. |
||
| 727 | Eastern Cooperative Oncology Group (ECOG) performance status >2. |
||
| 728 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 729 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 60%) |
||
| 730 | Eastern Cooperative Oncology Group (ECOG) performance status of 0–2 (Karnofsky > 80%) |
||
| 731 | Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed |
||
| 732 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 733 | Karnofsky performance status (KPS) performance status >= 60% or Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 |
||
| 734 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 735 | Performance Eastern Cooperative Oncology Group (ECOG) status of 0-2 |
||
| 736 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 737 | Have a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 738 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 739 | Patients must be medically fit to undergo surgery as determined by the treating medical and surgical oncology team and have Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 740 | Have a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 741 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0, 1, 2 |
||
| 742 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 743 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky >= 80 |
||
| 744 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 745 | Eastern Cooperative Oncology Group (ECOG, Appendix F) Performance Status of ? 1 |
||
| 746 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 747 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 748 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (within 28 days prior to enrollment) |
||
| 749 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 750 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 751 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 752 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 753 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 754 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 755 | Have a performance status of 0, to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; for purposes of HCT, this will correspond to a Karnofsky performance status of >= 80% |
||
| 756 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 757 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 758 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group scale. |
||
| 759 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 760 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 761 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale. |
||
| 762 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 763 | World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at enrollment |
||
| 764 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 765 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 766 | Eastern Cooperative Oncology Group (ECOG) performance status 3 or higher |
||
| 767 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 768 | Eastern Cooperative Oncology Group (ECOG) status of 0, 1, or 2. |
||
| 769 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 770 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 771 | Have a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) performance scale within 3 days of first dose of study drug |
||
| 772 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 773 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2. |
||
| 774 | Performance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale). |
||
| 775 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 776 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2; |
||
| 777 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 within 14 days prior to being registered for protocol therapy |
||
| 778 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 779 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 780 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 781 | Adequate performance status as follows\r\n* Patients >= 16 years must have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%)\r\n* Pediatric patients < 16 years must have Lansky play-performance of 60-100% |
||
| 782 | An Eastern Cooperative Oncology Grou (ECOG) performance status score of 0, 1, or 2. |
||
| 783 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1. |
||
| 784 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, with no deterioration over the previous 2 weeks. |
||
| 785 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 786 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky > 60%). |
||
| 787 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 788 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 789 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 790 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%). |
||
| 791 | Have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (see Appendix 14.3) |
||
| 792 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 793 | Eastern Cooperative Oncology Group (ECOG) status of 0, 1, or 2 within 28 days prior to registration |
||
| 794 | Have a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 795 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1 |
||
| 796 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 797 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 798 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 799 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, or Karnofsky >= 80% |
||
| 800 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 801 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 802 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 803 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 804 | ECOG (Eastern Cooperative Oncology Group) performance status score of 0 – 2 |
||
| 805 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 806 | Eastern Cooperative Oncology Group (ECOG) = 0, 1, or 2. |
||
| 807 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 808 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 809 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 810 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 811 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 812 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 813 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 814 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3, however grade 4 patients may be enrolled at the discretion of the treating radiation oncologist |
||
| 815 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 816 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 817 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 818 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 819 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (must be done within 7 days prior to study drug administration) |
||
| 820 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (Karnofsky >= 60%) |
||
| 821 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 822 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 823 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 824 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 825 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 826 | Karnofsky performance score >= 60 or Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better |
||
| 827 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 828 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1; |
||
| 829 | Have Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 830 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 831 | have an Eastern Cooperative Oncology Group (ECOG) performance status of ?1 (Appendix II); |
||
| 832 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 (Karnofsky >= 60%) |
||
| 833 | Eastern Cooperative Oncology Group (ECOG) score 0-1 |
||
| 834 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 835 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 836 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1; able to understand and sign the Informed Consent document |
||
| 837 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 838 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 839 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 840 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 841 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 842 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 843 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 844 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 845 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 846 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 847 | Eastern Cooperative Oncology Group (ECOG) performance score 0 or 1. |
||
| 848 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 849 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 850 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 851 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 852 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 853 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 854 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 855 | STUDY TREATMENT: Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 856 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 857 | An Eastern Cooperative Oncology Group performance status of 0 2 |
||
| 858 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 859 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 860 | Eastern Cooperative Oncology Group (ECOG) = 0, 1, or 2 |
||
| 861 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 862 | Patient Eastern Cooperative Oncology Group (ECOG) of 0-2, with life expectancy of at least 6 months |
||
| 863 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 864 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 865 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 866 | Eastern Cooperative Oncology Group (ECOG) performance status score 0-1 |
||
| 867 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 868 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 869 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 870 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 871 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 872 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 873 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 874 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 875 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 876 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 1 |
||
| 877 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 60%) |
||
| 878 | Performance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale). |
||
| 879 | Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 880 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) status of 0-2\r\n* NOTE: ECOG performance status 3 will be allowed only if thought to be directly secondary to adenoid cystic carcinoma disease by treating physician |
||
| 881 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1 |
||
| 882 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 883 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 884 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 885 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 within 28 days prior to randomization |
||
| 886 | Eastern Cooperative Oncology Group (ECOG) performance status < 4 |
||
| 887 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 888 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 889 | The patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 890 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 891 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 892 | Eastern Cooperative Oncology Group (ECOG) < 2 or Karnofsky >= 70 |
||
| 893 | Zubrod/Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 894 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 895 | Eastern Cooperative Oncology Group (ECOG) performance status score =< 2. |
||
| 896 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky >= 60%) |
||
| 897 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 898 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 899 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 900 | Eastern Co-operative Oncology Group (ECOG) performance status < or = 2. |
||
| 901 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 902 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 903 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-2. |
||
| 904 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 905 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 906 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 907 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 908 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 909 | Eastern Cooperative Oncology Group (ECOG) =< 2 (patients >= 16 years of age must have a Karnofsky performance level of >= 70% [or ECOG =< 2], and children < 16 years old must have a Lansky performance of >= 70%) |
||
| 910 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 911 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 912 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 913 | PHASE I: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 914 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 for MSS participants or < 2 for microsatellite instability (MSI) participants |
||
| 915 | Performance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 916 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 917 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 918 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 919 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 (Karnofsky > 60 %) |
||
| 920 | Must be ambulatory, with an Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1. |
||
| 921 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 922 | Eastern Cooperative Oncology Group (ECOG) performance status is 0-1 |
||
| 923 | Eastern Cooperative Oncology Group (ECOG) performance of 0 to 2 |
||
| 924 | Eastern Cooperative Oncology Group (ECOG) status of 0 to 1 |
||
| 925 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 2 |
||
| 926 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 927 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 928 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 929 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 930 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 931 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 932 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 933 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 934 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 935 | Eastern Cooperative Oncology Group (ECOG performance status of 0 or 1) |
||
| 936 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at initial screening and at baseline. |
||
| 937 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60) |
||
| 938 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 28 days prior to registration for protocol therapy |
||
| 939 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 940 | Must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 - 2. |
||
| 941 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 942 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 943 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 944 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky performance scale >= 70 |
||
| 945 | Performance status of Eastern Cooperative Oncology Group (ECOG) =< 2 or Karnofsky >= 60 % |
||
| 946 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 at study entry (Karnofsky >= 70) |
||
| 947 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 948 | Eastern Cooperative Oncology Group (ECOG) 0 or 1/Karnofsky performance status (KPS) 100-70% |
||
| 949 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 950 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 951 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 952 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 953 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 954 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 955 | Eastern Cooperative Oncology Group (ECOG) Performance status 0-1 |
||
| 956 | Eastern Cooperative Oncology Group (ECOG) 0-1 with life expectancy of >= 3 months |
||
| 957 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 958 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 959 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 960 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 961 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 962 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 963 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 964 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 965 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 966 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 967 | Eastern cooperative group (Eastern Cooperative Oncology Group [ECOG]) performance status =< 2 |
||
| 968 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 969 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 970 | Subjects with an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 971 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 972 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 973 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 974 | Eastern Cooperative Oncology Group (ECOG) 0 – 2 |
||
| 975 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 976 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 977 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 978 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 979 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 2 |
||
| 980 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 981 | Eastern Cooperative Oncology Group (ECOG) performance status >= 2 (Karnofsky >= 60 %) |
||
| 982 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 983 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 984 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 985 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 986 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2; (performance status of 3 will be allowed if poor performance status is thought to be directly secondary to ALL) |
||
| 987 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 with no deterioration over the previous 2 weeks and an estimated life expectancy of greater than 12 weeks |
||
| 988 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 989 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 990 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 991 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 992 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 993 | Eastern Cooperative Oncology Group(ECOG) Performance Status 0-1 |
||
| 994 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 995 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 996 | Eastern Cooperative Oncology Group (ECOG) performance status score less than or equal to (</=) 2 |
||
| 997 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 998 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 999 | An Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0, 1 or 2. |
||
| 1000 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 within 28 days prior to registration |
||
| 1001 | Eastern Cooperative Oncology Group (ECOG) status of 0-2 |
||
| 1002 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 1003 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 1004 | Eastern Cooperative Oncology Group Performance Status of 0 - 1 |
||
| 1005 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 |
||
| 1006 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1007 | Has Eastern Cooperative Group (ECOG) performance status of 0 or 1 |
||
| 1008 | Eastern Cooperative Group (ECOG) performance status of 0 or 1 |
||
| 1009 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1010 | Eastern Cooperative Oncology Group (ECOG) performance status 0 -1 (Karnofsky >= 70%) |
||
| 1011 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 (Karnofsky >= 50%) |
||
| 1012 | Performance status < 2 (Eastern Cooperative Oncology Group [ECOG]) |
||
| 1013 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at enrollment |
||
| 1014 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status =< 1 |
||
| 1015 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1016 | Eastern Cooperative Oncology Group (ECOG) of 0-2 |
||
| 1017 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1018 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 1019 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 80%) |
||
| 1020 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; patients with an ECOG performance status of 2 will be allowed at the discretion of the treating investigator in agreement with the sponsor-investigator |
||
| 1021 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1022 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 1023 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1024 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1025 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1026 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1027 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1028 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1029 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1030 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 1031 | Participant has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2 for Monotherapy and 0 to 1 for Combination. |
||
| 1032 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1033 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1034 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 1035 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 or greater, based on treating physician’s discretion |
||
| 1036 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1037 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1038 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1039 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1040 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1041 | Subjects must have a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1042 | Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status of 0 or 1 (Karnofsky >= 70%) |
||
| 1043 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1044 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1045 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1046 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1047 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1048 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1049 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 1050 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1051 | ECOG (Eastern Cooperative Oncology Group) performance status ? 2 |
||
| 1052 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1053 | Has a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale. |
||
| 1054 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 1055 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1056 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1057 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1058 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 (Appendix D). |
||
| 1059 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1060 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1061 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1062 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1063 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1064 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1065 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1066 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1067 | Eastern Cooperative Oncology Group (ECOG) score: 0 to 1 |
||
| 1068 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1069 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1070 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 1071 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1072 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1073 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1074 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1075 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 1076 | Have a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) performance scale within 7 days of first dose of study drug |
||
| 1077 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1078 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1079 | Have Eastern Cooperative Oncology Group (ECOG) scale performance status of 0 or 1. |
||
| 1080 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1081 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1082 | Eastern Cooperative Oncology Group (ECOG) performance status =<2 (Karnofsky >= 60%) |
||
| 1083 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1084 | Patients with Eastern Cooperative Oncology Group (ECOG) performance status 0-1 are eligible |
||
| 1085 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 1086 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1087 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1088 | Documented Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1089 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1, or Karnofsky score >= 70% |
||
| 1090 | European Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1091 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1092 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-2 |
||
| 1093 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-3 |
||
| 1094 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1095 | Eastern Cooperative Oncology Group (ECOG) performance status 0-4 |
||
| 1096 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1097 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 2 |
||
| 1098 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1099 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1100 | Eastern Cooperative Oncology Group (ECOG) performance status 0–1 |
||
| 1101 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 1102 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 1103 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1104 | Patients must have an ECOG (Eastern Cooperative Oncology Group) performance status 0 or 1. |
||
| 1105 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1106 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 1107 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1108 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1109 | Have a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale at the time of screening |
||
| 1110 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1111 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 at time of informed consent |
||
| 1112 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1113 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1114 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 1115 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1116 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1117 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or expected survival duration of > 2 months |
||
| 1118 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1119 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1120 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1121 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1122 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1123 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 1124 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1125 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1; |
||
| 1126 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1127 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1128 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1129 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 1130 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1131 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1132 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1133 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1134 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1135 | Eastern Cooperative Oncology Group performance status 0-1 |
||
| 1136 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1137 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1138 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 and fit for induction therapy in the opinion of the treating physician |
||
| 1139 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 or better |
||
| 1140 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1141 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1142 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1143 | History/physical examination, including breast exam and documentation of weight and Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 1144 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1145 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2, or 3, if the performance status of 3 is due to skin disease involvement |
||
| 1146 | Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 1147 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1148 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1149 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1150 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1151 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1152 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1153 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1154 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1155 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1156 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1157 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1158 | Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1159 | Eastern Cooperative Oncology Group (ECOG) performance score must be =< 2 within two weeks prior to registration |
||
| 1160 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 1161 | Eastern Cooperative Oncology Group performance status =< 1 |
||
| 1162 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1163 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1164 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 1165 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1166 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1167 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1168 | Documented Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1169 | Performance status (Eastern Cooperative Oncology Group [ECOG] 0 - 3 OR Karnofsky 100 - 30)(Recommended) |
||
| 1170 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky >= 70%) |
||
| 1171 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1172 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1173 | Eastern Cooperative Oncology Group (ECOG) performance status scores of 0, 1, or 2 |
||
| 1174 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1175 | Have an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1176 | PHASE I: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1177 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1178 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1179 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 14 days prior to being registered for protocol therapy |
||
| 1180 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1181 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1182 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1183 | Eastern Cooperative Oncology Group performance status of =< 2 |
||
| 1184 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1185 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1186 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1187 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1188 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry or Karnofsky >= 60% |
||
| 1189 | Adult patients with an Eastern Cooperative Oncology Group (ECOG) performance status 0-2 and a life expectancy of 3 months or more |
||
| 1190 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1191 | Eastern Cooperative Oncology Group (ECOG) of 0-2 |
||
| 1192 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1193 | Eastern Cooperative Oncology Group (ECOG) performance status of 3-4 |
||
| 1194 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1195 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 1196 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1197 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1198 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1199 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1200 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 1201 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1202 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status =< 2 |
||
| 1203 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1204 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 or Karnofsky performance status >= 70% |
||
| 1205 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1206 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1207 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1208 | The subject must have a performance status of 0-1 as determined by criteria set forward by the Eastern Cooperative Oncology Group |
||
| 1209 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1210 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1211 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1212 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1213 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance status (KPS) >= 50 |
||
| 1214 | Eastern Cooperative Oncology Group (ECOG) performance status 0, or 1 |
||
| 1215 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1216 | Have a performance status of =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1217 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1218 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1219 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1220 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 1221 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2. |
||
| 1222 | Karnofsky performance status (KPS) 70 or above, Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2 |
||
| 1223 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1224 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1225 | Karnofsky performance status (KPS) >= 70 or Eastern Cooperative Oncology Group (ECOG) 0 - 2 |
||
| 1226 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1227 | Performance status Eastern Cooperative Oncology Group (ECOG) =< 3 |
||
| 1228 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1229 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1230 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 1231 | Eastern Cooperative Oncology Group (ECOG) performance of 0-2 |
||
| 1232 | Patients must have a performance status of 0 - 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1233 | Have a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1234 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1235 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1236 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1237 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1238 | Eastern Co-operative Oncology Group (ECOG) performance status of ? 2. |
||
| 1239 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky > 70) |
||
| 1240 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1241 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 or KPS of 100% to 80% |
||
| 1242 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1243 | Karnofsky performance status (KPS) >= 70 or Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1244 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky > 60%) |
||
| 1245 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 1246 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1247 | Adequate performance status: Eastern Cooperative Oncology Group (ECOG) ? 2 |
||
| 1248 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1249 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1250 | Eastern Cooperative Oncology Group (ECOG) performance status >= 2 |
||
| 1251 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 1252 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 - 1 |
||
| 1253 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1254 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 (may be converted from Karnofsky performance status) |
||
| 1255 | Patients must have a performance status of 0 to 2 according to the Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 1256 | Patients must have a performance status of 0-2 (Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 1257 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 at registration |
||
| 1258 | Eastern Cooperative Oncology Group (ECOG) performance status 0?2 |
||
| 1259 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1260 | Eastern Cooperative Oncology Group (ECOG) performance score of 2 or better |
||
| 1261 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1262 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1263 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1264 | DONOR: Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1265 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1266 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1267 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1268 | Eastern Cooperative Oncology Group (ECOG) performance status assessment of 0 or 1 |
||
| 1269 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1270 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1271 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1272 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1273 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1274 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 1275 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1276 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 1277 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1278 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1279 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1280 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1281 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1282 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 1283 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1284 | Eastern Cooperative Oncology Group Performance Status 0 to 2 |
||
| 1285 | Current Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 through screening to first treatment on study |
||
| 1286 | Karnofsky performance status (KPS): >= 70% within 14 days before start of study treatment (Eastern Cooperative Oncology Group [ECOG] =< 1) |
||
| 1287 | Eastern Cooperative Oncology Group (ECOG) performance status < 1 (Karnofsky > 70%) |
||
| 1288 | Performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1289 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1290 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky >= 80%) |
||
| 1291 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1292 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1293 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or better |
||
| 1294 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1295 | Eastern Cooperative Oncology Group (ECOG) performance status that is either 0 or 1 |
||
| 1296 | CAPMATINIB INCLUSION CRITERIA: Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1297 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1298 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1299 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1300 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2; performance status of 3 permissible if related to disease |
||
| 1301 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1302 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 |
||
| 1303 | Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1304 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1305 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1306 | Participants must have Eastern Cooperative Oncology Group (ECOG) Performance Status 0 |
||
| 1307 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 3 |
||
| 1308 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1309 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1310 | Eastern Cooperative Oncology Group performance status of 0 to 1 |
||
| 1311 | Eastern Cooperative Oncology Group (ECOG) of ? 2. |
||
| 1312 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1313 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1314 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 1315 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1316 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1317 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1318 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1319 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1320 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1321 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 1322 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1323 | Karnofsky performance status >= 60 (Eastern Cooperative Oncology Group [ECOG] 0-2) |
||
| 1324 | Have an Eastern Cooperative Oncology Group (ECOG) Performance score =< 2 |
||
| 1325 | Eastern Cooperative Oncology Group (ECOG) performance status of 0/1 |
||
| 1326 | Eastern Cooperative Oncology Group (ECOG) score 0 |
||
| 1327 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1328 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale at study entry |
||
| 1329 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1330 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1331 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1332 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1333 | Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 1 |
||
| 1334 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1335 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1336 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1337 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1338 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1339 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1340 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1341 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1 (Appendix D) |
||
| 1342 | Have an Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 |
||
| 1343 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 1344 | Subject has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2. |
||
| 1345 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1346 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1347 | Eastern Cooperative Oncology Group (ECOG) performance status of ?1 |
||
| 1348 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1349 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1350 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1351 | Eastern Cooperative Oncology Group performance status must be 0 or 1, and life expectancy should be approximately 5 months or more. |
||
| 1352 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1353 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1354 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 - 1 within 30 days of signing informed consent |
||
| 1355 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1356 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1357 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 1358 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1359 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1360 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1361 | Unlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is 0-1 |
||
| 1362 | PHASE I STUDY ELIGIBILITY CRITERIA:\r\nEastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1363 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 |
||
| 1364 | Eastern Cooperative Oncology Group (ECOG) performance score of 2 or less |
||
| 1365 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1366 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1367 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 1368 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1369 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1370 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1371 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1372 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1373 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, 2, or 3 |
||
| 1374 | Adequate performance status: Eastern Cooperative Oncology Group (ECOG) ? 2 |
||
| 1375 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1376 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1377 | Have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1378 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1379 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 (Karnofsky >= 60%) |
||
| 1380 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1381 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1382 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1383 | Performance status of 0-2 by Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 1384 | The subject must have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1385 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1386 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1387 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1388 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1389 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2 (Appendix 3). |
||
| 1390 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1391 | Patients must have an Eastern Cooperative Oncology Group (ECOG) status of 0 to 2 |
||
| 1392 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1393 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1394 | Has a performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1395 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1396 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1397 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1398 | Have a performance status of 0 or 1 or 2 on the Eastern Cooperative Oncology Group (ECOG)\r\nperformance scale |
||
| 1399 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1400 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 1401 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1402 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1403 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1404 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1405 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 1406 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1407 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1408 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 at study entry (Karnofsky >= 70) |
||
| 1409 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1410 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 1411 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1412 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1413 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance scale |
||
| 1414 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1415 | Patients must have a performance status of Eastern Cooperative Oncology Group (ECOG) 0, 1, 2 |
||
| 1416 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1417 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1418 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1419 | Eastern Cooperative Oncology Group (ECOG) performance status of zero, one, or two |
||
| 1420 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 50%) |
||
| 1421 | INCLUSION CRITERIA FOR ENROLLMENT: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance scale (KPS) >= 70% |
||
| 1422 | INCLUSION CRITERIA FOR ADDITIONAL PTCy-MILs INFUSION AT RELAPSE: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance scale (KPS) >= 70% |
||
| 1423 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 1424 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1425 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1426 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1427 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 |
||
| 1428 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 1429 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1430 | Eastern Cooperative Oncology Group performance status of 0 to 1. |
||
| 1431 | Patient must have performance status =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1432 | Has an Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 1433 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 1434 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1435 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1436 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1437 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1438 | Eastern Cooperative Oncology Group (ECOG) performance status score of < or =< 2 |
||
| 1439 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1440 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1441 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1442 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1443 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 (3 if it is directly disease related and is expected to get better if the acute lymphoblastic leukemia/lymphoma [ALL] is under control) |
||
| 1444 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1445 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1446 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1447 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 80%) |
||
| 1448 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 within 30 days of registration |
||
| 1449 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1450 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1451 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 1452 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky > 60%) |
||
| 1453 | Eastern Cooperative Oncology Group (ECOG) performance status being 0-3 |
||
| 1454 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1455 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1456 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1457 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 1458 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1459 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1460 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1461 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1462 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1463 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1464 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1465 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1466 | Zubrod performance status =< 3 (Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 1467 | Eastern Cooperative Oncology Group (ECOG) performance statuses of 0, 1, or 2 |
||
| 1468 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1469 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1470 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 or Karnofsky performance status >= 80% |
||
| 1471 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1472 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 60%) |
||
| 1473 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1474 | Eastern Cooperative Oncology Group (ECOG) performance status must be level 0 or 1 within 60 days prior to registration |
||
| 1475 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1476 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1477 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1478 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 1479 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 1 |
||
| 1480 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 |
||
| 1481 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1482 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1483 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1484 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1485 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1486 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 at study entry |
||
| 1487 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 1488 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1489 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1490 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1491 | Eastern Cooperative Oncology Group (ECOG) performance status of < or = 3 |
||
| 1492 | Adequate performance status (Eastern Cooperative Oncology Group [ECOG] < 3) and research participant does not require mechanical ventilation |
||
| 1493 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1494 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1495 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1496 | Eastern Cooperative Oncology Group (ECOG) performance status 0. |
||
| 1497 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%, Lansky >= 60%) |
||
| 1498 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1499 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1500 | Patient must have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1501 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1502 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1503 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1504 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1505 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1506 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1507 | Eastern Cooperative Oncology Group (ECOG) performance status score 0 - 2 |
||
| 1508 | All case Eastern Cooperative Oncology Group (ECOG) performance score equal to or less than 2 |
||
| 1509 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1510 | Eastern Cooperative Oncology Group (ECOG) Performance Status ?1. |
||
| 1511 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-1 |
||
| 1512 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1513 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1514 | Eastern Cooperative Oncology Group (ECOG) performance status of 3 or more or Lanksy performance status of < 40 |
||
| 1515 | An Eastern Cooperative Oncology Group (ECOG) performance status that is either 0 or 1 |
||
| 1516 | Performance status (Eastern Cooperative Oncology Group [ECOG]) 0 or 1 |
||
| 1517 | Eastern Clinical Oncology Group performance status 0 or 1 |
||
| 1518 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1519 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1520 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 1521 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1522 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 1523 | The patient's Eastern Cooperative Oncology Group (ECOG) performance status is =< 2 |
||
| 1524 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1525 | Eastern Cooperative Oncology Group (ECOG) performance status greater than 2 |
||
| 1526 | Eastern Cancer Oncology Group (ECOG) performance status 0 or 1 |
||
| 1527 | Performance status (World Health Organization [WHO]/Eastern Cooperative Oncology Group [ECOG] scale) 0-2 |
||
| 1528 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1529 | Eastern Cooperative Oncology Group (ECOG) performance status of 1 or better (corresponds to Karnofsky performance status [KPS] of >= 70) |
||
| 1530 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1531 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1532 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1533 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1534 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 within 30 days of signing informed consent (Turnstile I) |
||
| 1535 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1536 | Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of 0-2 |
||
| 1537 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1538 | Performance status: Eastern Cooperative Oncology Group (ECOG) 2 or less or Karnofsky of at least 60 |
||
| 1539 | Eastern Clinical Oncology Group performance status 0 or 1 |
||
| 1540 | Eastern Cooperative Oncology Group (ECOG) performance score of =< 2 |
||
| 1541 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1542 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 |
||
| 1543 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 80%) |
||
| 1544 | Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status between 0-2 |
||
| 1545 | Performance status Eastern Cooperative Oncology Group (ECOG) 0, 1 |
||
| 1546 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1547 | Relapsed/refractory MCL: Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1548 | Newly diagnosed MCL: Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1549 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1550 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1551 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1552 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1553 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1554 | Eastern Cooperative Oncology Group (ECOG) performance status of either 0 or 1 |
||
| 1555 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) scale of 0-2 |
||
| 1556 | Eastern Cooperative Oncology Group performance status of one or less |
||
| 1557 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1558 | Baseline Eastern Cooperative Oncology Group (ECOG) Clinical Performance Status 0 or 1 |
||
| 1559 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1560 | Karnofsky performance status >= 70 or Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1561 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1562 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1563 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1564 | Subjects must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1565 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 1566 | Performance 0-3 (Eastern Cooperative Oncology Group [ECOG]) |
||
| 1567 | Eastern Cooperative Oncology Group (ECOG) performance score must be =< 2 within two weeks prior to registration |
||
| 1568 | Eastern Cooperative Oncology Group (ECOG) performance status being 0-2 |
||
| 1569 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 1570 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1571 | Eastern Cooperative Oncology Group (ECOG) performance 0?2 |
||
| 1572 | Must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1573 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1574 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 within 30 days of signing informed consent (Turnstile I) |
||
| 1575 | Performance score of at least 70% by Karnofsky or 0 to 2 Eastern Cooperative Oncology Group (ECOG) |
||
| 1576 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 1577 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1578 | Patient must have performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) performance scale and life expectancy > 3 months |
||
| 1579 | Performance score of at least 80% by Karnofsky or 0 to 2 Eastern Cooperative Oncology Group (ECOG) |
||
| 1580 | Baseline Eastern Cooperative Oncology Group (ECOG) clinical performance status 0 or 1 |
||
| 1581 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1582 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1583 | Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 1584 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1585 | Patients must have a performance status 0 or 1 by Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 1586 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1587 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1588 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 1 or Karnofsky performance status >= 70 |
||
| 1589 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1590 | Eastern Cooperative Oncology Group (ECOG) performance status should be less or equal to 3 |
||
| 1591 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1592 | Patient must have performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale and life expectancy > 3 months |
||
| 1593 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1594 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1595 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1596 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1597 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1598 | Patient’s Eastern Cooperative Oncology Group (ECOG) performance status must be =< 2 (Karnofsky >= 60%) |
||
| 1599 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1600 | Performance status of Karnofsky performance scale (KPS) >= 60 or Eastern Cooperative Oncology Group (ECOG) = 0, 1, or 2 |
||
| 1601 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 1602 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1603 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1604 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1605 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1606 | Southwest Oncology Group (SWOG)/Eastern Cooperative Oncology Group (ECOG) performance score >= 2 |
||
| 1607 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 study entry |
||
| 1608 | Performance status =< 2 (Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 1609 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1610 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1611 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 1612 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1613 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1614 | Eastern Cooperative Oncology Group (ECOG) performance score of less than or equal to |
||
| 1615 | Performance status (Eastern Cooperative Oncology Group; ECOG) of 0-2. |
||
| 1616 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1617 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 1618 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1619 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 1620 | Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 1621 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 within 7 days prior to registration |
||
| 1622 | Performance status 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 1623 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1624 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 1625 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1626 | Eastern Cooperative Oncology Group (ECOG) performance status < 1 |
||
| 1627 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1628 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1629 | Eastern Cooperative Group (ECOG) performance status =< 1 |
||
| 1630 | Eastern Cooperative Oncology Group (ECOG) performance status 2 or better |
||
| 1631 | Patients must be ambulatory with an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1632 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1633 | Karnofsky performance status >= 70 (Eastern Cooperative Oncology Group [ECOG] 0-1) |
||
| 1634 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1635 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky or Lansky score >= 60 |
||
| 1636 | Eastern Cooperative Oncology Group (ECOG) Performance Status Score 0 - 1 |
||
| 1637 | Performance status evaluated by Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance scales (KPS) patients must have a score of 0-II (ECOG) or >= 70% (KPS) |
||
| 1638 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1639 | Performance status: Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1640 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 and life expectancy greater than 12 weeks based on the investigator's clinical judgment |
||
| 1641 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1642 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 1643 | Eastern Cooperative Oncology Group (ECOG) status 0-1 documented within 90 days of registration |
||
| 1644 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1645 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 at registration |
||
| 1646 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1647 | Patients with an Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1 |
||
| 1648 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1649 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1650 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1651 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1652 | Karnofsky score >= 70; (Eastern Cooperative Oncology Group [ECOG] 0-2) |
||
| 1653 | Participants will not be excluded based on performance status; for patients with Eastern Cooperative Oncology Group (ECOG) performance status >= to 3 the dosing schedule will be discussed with study chairman |
||
| 1654 | Patients > 70 may be considered if performance status > 80% or Eastern Cooperative Oncology Group (ECOG) =< 1 and comorbidity score < 3; these patients must be discussed with the principal investigator (PI), Rachel Salit prior to enrollment |
||
| 1655 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1656 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 1657 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1658 | Eastern Cooperative Oncology Group (ECOG) performance status score 0 - 2 |
||
| 1659 | Eastern Cooperative Oncology Group (ECOG) Performance Status Score 0-2 |
||
| 1660 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 3 |
||
| 1661 | Good performance status (Eastern Cooperative Oncology Group [ECOG] 0 or 1; Karnofsky and Lansky 70-100) |
||
| 1662 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 (Turnstile I) |
||
| 1663 | Subjects performance status must be (Karnofsky performance status [KPS] greater than or equal to 50; Eastern Cooperative Oncology Group [ECOG] less than or equal to 2) |
||
| 1664 | Eastern Cooperative Oncology Group (ECOG) performance status 0-4 |
||
| 1665 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 1666 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1667 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1668 | Eastern cooperative oncology group (ECOG) performance status of 0-2 with a life expectancy ? 6 months |
||
| 1669 | Eastern Cooperative Oncology Group (ECOG) Performance Status ?1; |
||
| 1670 | Have an Eastern Cooperative Oncology Group (ECOG) score of 0, 1, or 2. |
||
| 1671 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 prior to randomization |
||
| 1672 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1673 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; |
||
| 1674 | Easter Cooperative Oncology Group (ECOG) Performance Status ? 1 |
||
| 1675 | ECOG (Eastern Cooperative Oncology Group) Performance Status of 0 or 1 |
||
| 1676 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 1677 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1678 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1679 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1680 | Eastern Cooperative Oncology Group performance status of 0 or 1. |
||
| 1681 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1682 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 1683 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 60%) |
||
| 1684 | Eastern Cooperative Oncology Group (ECOG) performance status grade less than or equal to (<=) 2 |
||
| 1685 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 1686 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1687 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1688 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1689 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 within 14 days prior to registration for protocol therapy |
||
| 1690 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1691 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1692 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1693 | Eastern Cooperative Oncology Group (ECOG) Performance Status ? 2 |
||
| 1694 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 at time of enrollment. |
||
| 1695 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 1696 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1697 | Has an Eastern Cooperative Oncology Group Performance Status 0-1 |
||
| 1698 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 1699 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1700 | Eastern Cooperative Oncology Group (ECOG) performance status of 0–2 |
||
| 1701 | Eastern cooperative oncology group (ECOG) performance score of 0 or 1 |
||
| 1702 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1703 | Eastern Cooperative oncology Group (ECOG) performance status score ? 2 |
||
| 1704 | Eastern Cooperative Oncology Group (ECOG) performance score of 0?1 |
||
| 1705 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 1706 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1707 | Have Eastern Cooperative Oncology Group (ECOG) performance status of ? 1 |
||
| 1708 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1709 | Eastern Cooperative Oncology Group performance score 0 to 2; |
||
| 1710 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1711 | Eastern Cooperative Oncology Group (ECOG) performance score of 0, 1 or 2 |
||
| 1712 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1713 | Performance score of at least 80% by Karnofsky or 0 to 2 Eastern Cooperative Oncology Group (ECOG) |
||
| 1714 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1715 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1716 | Patients must be Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1717 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 1718 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 1719 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1720 | Eastern Cooperative Oncology Group (performance status of ?20 |
||
| 1721 | Eastern Cooperative Oncology Group (ECOG) status of <2 |
||
| 1722 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1723 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1724 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status score = 0 or 1 |
||
| 1725 | Subjects with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 1726 | Subjects who have a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 1727 | 108 Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1728 | Eastern Cooperative Oncology Group (ECOG) performance status ?2. |
||
| 1729 | Eastern Cooperative Oncology Group performance status 0 to 2. |
||
| 1730 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1731 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 1732 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 within 28 days prior to registration |
||
| 1733 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1 |
||
| 1734 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1735 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 1736 | Eastern Cooperative Oncology Group (ECOG) performance status of < 2 |
||
| 1737 | ORAL CAVITY SQUAMOUS CELL CARCINOMA COHORT: Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 1738 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 1739 | 5. Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 1740 | Eastern Cooperative Oncology Group performance status 0 to 2 |
||
| 1741 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 1742 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1. |
||
| 1743 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 1744 | An Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to |
||
| 1745 | Eastern Cooperative Oncology Group (ECOG) performance status < 3 |
||
| 1746 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1747 | Eastern Cooperative Oncology Group performance status score of 0 or 1. |
||
| 1748 | ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1 |
||
| 1749 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 1750 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1751 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 7 days prior to the first dose of study treatment but before randomization. |
||
| 1752 | Eastern Cooperative Oncology Group (ECOG) performance status of ?1 |
||
| 1753 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 1754 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1755 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1756 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 1757 | Eastern Cooperative Oncology Group (ECOG) performance status of <2. |
||
| 1758 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 2 |
||
| 1759 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 1760 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1761 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 1762 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 1763 | Adequate performance status: Eastern Cooperative Oncology Group (ECOG) ? 2 |
||
| 1764 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1765 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1766 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1767 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2, and estimated survival of at least 3 months |
||
| 1768 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 and fit for induction therapy in the opinion of the treating physician |
||
| 1769 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1770 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1771 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1772 | REGISTRATION TO TREATMENT (STEP 1): Patients have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1773 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2, or 3 |
||
| 1774 | Performance status < 2 (Eastern Cooperative Oncology Group [ECOG]) |
||
| 1775 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1776 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1777 | Must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 1778 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 1779 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 80%) |
||
| 1780 | Eastern Cooperative Oncology Group (ECOG) performance status grade 0 or 1 |
||
| 1781 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1782 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1783 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 and expected survival > 3 months from study enrollment |
||
| 1784 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1785 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1786 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1787 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1788 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1789 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1790 | Eastern Cooperative Oncology Group (ECOG)/ Zubrod performance status of ‘0-1’ |
||
| 1791 | Eastern Cooperative Oncology Group performance status of 0-2 |
||
| 1792 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1793 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1794 | Have a performance status of 0 - 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1795 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1796 | Patients 18 to =< 45 years: Karnofsky (>= 18 years old) >= 70 or Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 1797 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1798 | Eastern Cooperative Oncology Group (ECOG) performance status being 0-1 within 1 week of planned start of therapy |
||
| 1799 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1800 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1801 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1802 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1803 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1804 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1805 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 1806 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 1807 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1808 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 within 28 days prior to registration |
||
| 1809 | Eastern Cooperative Oncology Group (ECOG) performance status < 2. |
||
| 1810 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1811 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less. |
||
| 1812 | FOR TISSUE COLLECTION TO ESTABLISH PDX (PART 1): Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 1813 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1814 | Eastern Cooperative Oncology (ECOG) performance status of 0 to 1 |
||
| 1815 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1816 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1817 | Patients must have a performance status of Eastern Cooperative Oncology Group (ECOG) 0, 1, or 2 |
||
| 1818 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1819 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1820 | Eastern Cooperative Oncology Group (ECOG) performance status 0?3 |
||
| 1821 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1822 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 50%) |
||
| 1823 | Eastern Cooperative Oncology Group (ECOG)/ Zubrod performance status of 0 or 1 |
||
| 1824 | The participant must have an Eastern Cooperative Oncology Group (ECOG) score between 0 - 2 at screening |
||
| 1825 | Eastern cooperative oncology group (ECOG) performance status of =< 2 |
||
| 1826 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 to 2 |
||
| 1827 | Performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1828 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 28 days prior to registration for protocol therapy |
||
| 1829 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 1830 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1831 | Karnofsky performance score >= 70 or Eastern Cooperative Oncology Group (ECOG) performance status = 0 or 1 |
||
| 1832 | Eastern Cooperative Oncology Group (ECOG) performance status of 0?1 |
||
| 1833 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1834 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1835 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1836 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2, life expectancy > 3 months |
||
| 1837 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1838 | Karnofsky >= 70% (Eastern Cooperative Oncology Group [ECOG] performance status 0-1) |
||
| 1839 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1840 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1841 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1842 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1843 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1844 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1845 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 1846 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 1847 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 1848 | Performance status </=2 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 1849 | Participant must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1850 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1851 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1852 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1853 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky > 60%) |
||
| 1854 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1855 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1856 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1857 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1858 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 1859 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 |
||
| 1860 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1861 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1 or 2 |
||
| 1862 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1863 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1864 | Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1865 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1866 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1867 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 1868 | The subject must have a performance status of 0-2 as determined by criteria set forward by the Eastern Cooperative Oncology Group |
||
| 1869 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1870 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1871 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1872 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1873 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 1874 | Eastern Cooperative Oncology Group performance score (ECOG) ? 2 |
||
| 1875 | Eastern Cooperative Oncology Group (ECOG) performance status score less than or equal to (</=) 2 |
||
| 1876 | Subjects with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1877 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2. |
||
| 1878 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 / Karnofsky > 60% |
||
| 1879 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1880 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1881 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1882 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1883 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1884 | DOSE ESCALATION COHORT: Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1885 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1886 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 50%) |
||
| 1887 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1888 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1889 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status score ? 2 |
||
| 1890 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 1891 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 1892 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 within 30 days prior to registration. |
||
| 1893 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky >= 70% |
||
| 1894 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1895 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1896 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 60%) |
||
| 1897 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1898 | Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 1899 | Performance status (Eastern Cooperative Oncology Group [ECOG]/Karnofsky) of 0, 1 or 2 within 28 days prior to registration |
||
| 1900 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1901 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 at time of study entry |
||
| 1902 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1903 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1904 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 1905 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1906 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1907 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 or 2 |
||
| 1908 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 1909 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1910 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1911 | Have a performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1912 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1913 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1914 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1915 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1916 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 1917 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1918 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2. |
||
| 1919 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1920 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1921 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1922 | PSTAT3 SCREENING: Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1923 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1924 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1925 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1926 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 with greater than six week life expectancy |
||
| 1927 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1928 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1929 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance\n status of 0 to 1. |
||
| 1930 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1931 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1932 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 14 days before registration for protocol therapy |
||
| 1933 | The Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60 %) |
||
| 1934 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 (Karnofsky >= 60%) and a life expectancy of at least 3 months; evaluation of ECOG is to be performed within 7 days prior to the date of allocation/randomization |
||
| 1935 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1936 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1937 | Performance 0-2 (Eastern Cooperative Oncology Group [ECOG]). |
||
| 1938 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 1939 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1940 | ECOG (Eastern Cooperative Oncology Group) performance status 0-1 |
||
| 1941 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 1942 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 or a Karnofsky performance status of >= 80% |
||
| 1943 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 1944 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1945 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1946 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1947 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 1948 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1949 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 1950 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 1951 | Performance status Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 1952 | Patients must have a performance status of =< 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1953 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky > 60%) |
||
| 1954 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1955 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 1956 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1957 | Eastern Cooperative Oncology Group - ECOG performance status =< 2 |
||
| 1958 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 1959 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1960 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status 0-2 |
||
| 1961 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%) |
||
| 1962 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1963 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1964 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1965 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1966 | Performance status: patients must have an Eastern Cooperative Oncology Group (ECOG) =< 2 (Karnofsky >= 60%) |
||
| 1967 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1968 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1969 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 1970 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 1971 | Performance status of 2 or better as per Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 1972 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 1973 | Easter Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 1974 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale; (>= 70% Karnofsky performance score) |
||
| 1975 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or1 |
||
| 1976 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1977 | Eastern Cooperative Oncology Group (ECOG) performance score 0-1 |
||
| 1978 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1979 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1980 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1981 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1982 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 1983 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 1984 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 1985 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1986 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 1987 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1988 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1989 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1990 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 1991 | Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2, or for children =< 10 years of age, Lansky >= 60 |
||
| 1992 | Performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 1993 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, 2, or 3 |
||
| 1994 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 1995 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (Karnofsky > 70%) |
||
| 1996 | Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1 or 2; use Lansky for patients =< 16 years of age |
||
| 1997 | Eastern Cooperative Oncology Group (ECOG) performance status 0 -1 |
||
| 1998 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 1999 | The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2000 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at initial enrollment, as assessed by clinician or investigator |
||
| 2001 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2002 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2003 | Eastern Cooperative Oncology Group (ECOG) performance status 0–1 (Karnofsky >= 70%) |
||
| 2004 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 or Karnofsky\r\n>= 60% |
||
| 2005 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2006 | Eastern Cooperative Oncology Group (ECOG) performance status typically =< 1 (Karnofsky >= 70%) |
||
| 2007 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2008 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2009 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2010 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 at study entry (Karnofsky >= 70) |
||
| 2011 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2012 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 2013 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 2014 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2015 | Life expectancy of >= 6 months, Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2016 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 2017 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2018 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2019 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 |
||
| 2020 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky 80%-100%) |
||
| 2021 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2022 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2023 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2024 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2025 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2026 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 - 1; ECOG performance status of 0-1 will be inferred if the patient’s level of energy is >= 50% of baseline |
||
| 2027 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2028 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2029 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 - 1; ECOG performance status of 0-1 will be inferred if the patient's level of energy is >= 50% of baseline |
||
| 2030 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2031 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2032 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 (Karnofsky ? 60%) |
||
| 2033 | Patients must have an Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of 0-2 |
||
| 2034 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2035 | ECOG (Eastern Cooperative Oncology Group) Performance Score ? 1. |
||
| 2036 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2037 | Karnofsky performance status of 70% or greater (Eastern Cooperative Oncology Group [ECOG] 0 or 1) |
||
| 2038 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2039 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2040 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2041 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2042 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 2043 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2044 | Patients have Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2045 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2046 | Performance Status: Eastern Cooperative Oncology Group (ECOG) 0-1 unless mobility is limited from chronic physical handicap |
||
| 2047 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 (Karnofsky >= 60%) |
||
| 2048 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2049 | Eastern Cooperative Oncology Group (ECOG) 0, 1 or 2; or Karnofsky of >= 60, or for children =< 10 years of age, Lansky >= 60 |
||
| 2050 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2051 | Eastern Cooperation Oncology Group (ECOG) performance status 0-2 |
||
| 2052 | Eastern Cooperative Oncology Group (ECOG) performance status score 0 or 1 |
||
| 2053 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 2054 | Patients must have Eastern Cooperative Oncology Group (ECOG)-American College of Radiology Imaging Network (ACRIN) performance status of 0-2 |
||
| 2055 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2 |
||
| 2056 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2057 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2058 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2059 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2060 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2061 | Eastern Cooperative Oncology Group (ECOG) performance status equal to 0 or 1 |
||
| 2062 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2063 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2064 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 2065 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2066 | Eastern Cooperative Oncology Group (ECOG) status 2 or less |
||
| 2067 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2068 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 10 days prior to study start |
||
| 2069 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 2070 | Eastern Cooperative Oncology Group (ECOG) performance less than or equal to 2 |
||
| 2071 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2072 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 2073 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2. |
||
| 2074 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 at the time of informed consent |
||
| 2075 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2076 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2077 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 2078 | The participant has an Eastern Cooperative Oncology Group performance status of 0 or |
||
| 2079 | Participant must have an Eastern Cooperative Oncology Group (ECOG) performance score of 0 - 1. |
||
| 2080 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 2081 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2082 | Performance status ECOG 0-1 (Eastern Cooperative Oncology Group) |
||
| 2083 | Has a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 7 days of first dose of study drug. |
||
| 2084 | Eastern Cooperative Oncology Group status of 0 or 1 |
||
| 2085 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2086 | Eastern Cooperative Oncology Group (ECOG) Performance status 0-2 |
||
| 2087 | Performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) |
||
| 2088 | Has a performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale for Cohorts A and C and a performance status of 0 or 1 for Cohort B within 10 days of study start |
||
| 2089 | Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 2090 | Eastern Cooperative Oncology Group (ECOG) performance of 0 to 2 |
||
| 2091 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 2092 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 2093 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 3 days prior to first dose of study medication |
||
| 2094 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2095 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 2096 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1. |
||
| 2097 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2098 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2099 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2100 | Patients who have received one prior regimen must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2; patients who have received two or three prior regimens must have an ECOG performance status of 0 or 1 |
||
| 2101 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2102 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2103 | Has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2. |
||
| 2104 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 2105 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2106 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2107 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2108 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 10 days prior to study start |
||
| 2109 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2110 | Participant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2111 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2112 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2113 | Eastern Cooperative Oncology Group (ECOG) of 0 or 1 |
||
| 2114 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at the time of randomization |
||
| 2115 | Eastern Cooperative Oncology Group (ECOG) performance status of ?2. |
||
| 2116 | An Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1. |
||
| 2117 | Has performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 2118 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 2119 | Has performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 2120 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2121 | Eastern Cooperative Oncology Group (ECOG) performance status that is either 0 or 1 at screening |
||
| 2122 | Patient has Eastern Cooperative Oncology Group (ECOG) performance status 2 or more |
||
| 2123 | Have an Eastern Cooperative Oncology Group (ECOG) of 0 or 1. |
||
| 2124 | Eastern Cooperative Oncology Group Performance Status of 0-1 |
||
| 2125 | Subject has Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 2126 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2127 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 1 |
||
| 2128 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2129 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2130 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2131 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 2132 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2133 | Eastern Cooperative Oncology Group (ECOG) status of 0 to 1 |
||
| 2134 | Performance status of 2 or better as per Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 2135 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2136 | Performance status Eastern Cooperative Oncology Group (ECOG) 0, 1, or 2 |
||
| 2137 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2138 | ECOG (Eastern Cooperative Oncology Group) performance status 0-1 |
||
| 2139 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2140 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2141 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2142 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2143 | Eastern Cooperative Oncology Group (ECOG) performance status = 0, 1, or 2 |
||
| 2144 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2145 | Eastern Cooperative Oncology Group (ECOG) Performance Status ? 2. |
||
| 2146 | Current Eastern Cooperative Oncology Group (ECOG) of 0-1 through screening to first treatment on study |
||
| 2147 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 at Screening |
||
| 2148 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 2149 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky > 60%) |
||
| 2150 | Eastern Cooperative Oncology Group (ECOG) performance status 0- 1. |
||
| 2151 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 60%) |
||
| 2152 | Eastern Cooperative Oncology Group (ECOG) performance status of ?2. |
||
| 2153 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2154 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 |
||
| 2155 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2156 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 2157 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale |
||
| 2158 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2159 | Eastern Collaborative Oncology Group (ECOG) performance score of less than or equal to |
||
| 2160 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 2161 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 2162 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2163 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status. |
||
| 2164 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2165 | Have a performance status of 0 to 2 on the Eastern Cooperative Oncology Group (ECOG) scale for adults. |
||
| 2166 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2167 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2168 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 1. |
||
| 2169 | Eastern Cooperative Oncology Group (ECOG) performance status >2. |
||
| 2170 | Eastern Cooperative Oncology Group performance status 0 to 1 |
||
| 2171 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2172 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2173 | Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) performance status 0-1 |
||
| 2174 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2175 | ECOG [Eastern Cooperative Oncology Group] Performance Status 0 or 1. |
||
| 2176 | Eastern Cooperative Oncology Group Performance Status >=2 |
||
| 2177 | Part A and C: Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2178 | Part B: Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 2179 | Eastern Cooperative Oncology Group (ECOG) performance status grade of 0 or 1 |
||
| 2180 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2181 | Eastern Cooperative Oncology Group (ECOG) performance status - 0, 1, 2, 3 |
||
| 2182 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2183 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2184 | Eastern Cooperative Oncology Group score ? 2 |
||
| 2185 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2186 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2187 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2188 | Participant must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0 to 1. |
||
| 2189 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 2190 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or |
||
| 2191 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2. |
||
| 2192 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 1 |
||
| 2193 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2194 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2195 | Has performance status of 0, 1, or 2 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 2196 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2197 | AMKL PATIENTS: Patients must have an Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 2198 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (R01-0787) |
||
| 2199 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2200 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2201 | Eastern Cooperative Oncology Group (ECOG) Performance status less than or equal to (</=) 2 (for dose-escalation part) and 0 or 1 (for dose-expansion part) |
||
| 2202 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-2 |
||
| 2203 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2204 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2205 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 2206 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 2207 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 2208 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; |
||
| 2209 | Eastern Cooperative Oncology Group performance status score of 0, 1, or 2 |
||
| 2210 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 2211 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2212 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2213 | Have a performance status of less than or equal to 1 on the Eastern Cooperative Oncology Group (ECOG) scale and life expectancy of more than 12 weeks. |
||
| 2214 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 2215 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1 |
||
| 2216 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 2217 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2218 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2219 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2220 | Eastern Cooperative Oncology Group (ECOG) 0-4 |
||
| 2221 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2222 | Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 1 |
||
| 2223 | Eastern Cooperative Oncology Group performance status ? 2. |
||
| 2224 | Eastern Cooperative Oncology Group performance status 0 to 2. |
||
| 2225 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2226 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 2227 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2228 | Eastern Cooperative Oncology Group performance status ?2 |
||
| 2229 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 2230 | Have Eastern Cooperative Oncology Group (ECOG) performance status ?2. |
||
| 2231 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 1. |
||
| 2232 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 2233 | The Eastern Cooperative Oncology Group (ECOG) performance status must be 0-1 |
||
| 2234 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2235 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 2236 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2237 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 2238 | The Eastern Cooperative Oncology Group (ECOG) Performance Status 0, 1 or 2 |
||
| 2239 | World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at enrollment |
||
| 2240 | Eastern Cooperative Oncology Group (ECOG) ? 1 |
||
| 2241 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 |
||
| 2242 | Have an Eastern Cooperative Oncology Group Performance Status of 0 or 1. |
||
| 2243 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2244 | Must have Eastern Cooperative Oncology Group (ECOG) Performance score of 0, 1, or 2. |
||
| 2245 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2246 | Eastern Cooperative Oncology Group 0 to 2 |
||
| 2247 | Performance status ? 2 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 2248 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2249 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 2250 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2251 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2252 | Eastern Cooperative Oncology Group (ECOG) performance status must be < 2 |
||
| 2253 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2254 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2255 | The subject has an Eastern Cooperative Oncology Group performance (ECOG) status ? 1 at Screening and Day 1 |
||
| 2256 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2257 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2258 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status scale |
||
| 2259 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2260 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2. (Appendix F); |
||
| 2261 | Eastern Cooperative Oncology Group (ECOG) performance status 0 -2 |
||
| 2262 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 2263 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2. |
||
| 2264 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2265 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2266 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2267 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2268 | Eastern Cooperative Oncology Group (ECOG) performance status < 3 at enrollment is required |
||
| 2269 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1. |
||
| 2270 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 -2 at study entry |
||
| 2271 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2272 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2273 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 within 14 days prior to randomization. |
||
| 2274 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 2275 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2276 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2277 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2, or 3 within 28 days prior to registration |
||
| 2278 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 2279 | Eastern Cooperative Oncology Group performance status superior to 2. |
||
| 2280 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2281 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 2282 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 2283 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 2284 | Eastern Cooperative Oncology Group Performance Status: 0-1 |
||
| 2285 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2286 | Eastern cooperative oncology group (ECOG) performance status =< 2 |
||
| 2287 | Eastern Cooperative Oncology Group (ECOG) performance score of ? 1 |
||
| 2288 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2289 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 2290 | Subjects must have ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1 |
||
| 2291 | Eastern Cooperative Oncology Group (ECOG) performance score less than or equal to 2 |
||
| 2292 | have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group scale |
||
| 2293 | Subject who has the Eastern Cooperative Oncology Group performance status of 0, 1, or |
||
| 2294 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 2295 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 2296 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2297 | Have an Eastern Cooperative Oncology Group performance status of 0 or 1. |
||
| 2298 | Has a performance status of 0 or 1 using the Eastern Cooperative Oncology Group (ECOG) Performance Scale within 7 days of first dose of study drug |
||
| 2299 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 2300 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2301 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2302 | Performance status with Eastern Cooperative Oncology Group (ECOG) score =< 2; patients with performance status of 3 may be considered as long as the decline has been of short duration (< 1 month), and is due to their malignancy and not a comorbid condition (example: pain limiting activity) |
||
| 2303 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 2304 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 2305 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 2306 | ECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2 within 28 days prior to registration. ECOG Performance Status of 3 will only be allowed if judged by the treating investigator as attributable exclusively to bone pain. |
||
| 2307 | Eastern Cooperative Oncology Group performance status of 0-2 |
||
| 2308 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2309 | Participant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2310 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2311 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2312 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2313 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2314 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2315 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2316 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2317 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2318 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2319 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 2320 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 2321 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2322 | Eastern Cooperative Oncology Group (ECOG) performance score < 2 |
||
| 2323 | Eastern Cooperative Oncology Group (ECOG) performance status of ?1. |
||
| 2324 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2325 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2326 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 2327 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2328 | Eastern Cooperative Oncology Group (ECOG) performance status <2. |
||
| 2329 | Subjects with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 2330 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2331 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2332 | Have a confirmed diagnosis of intermediate or high-risk SMM, and an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. |
||
| 2333 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group scale at baseline. |
||
| 2334 | Eastern Cooperative Oncology Group [ECOG] 0-1 |
||
| 2335 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2336 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 2337 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2338 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2339 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2340 | Performance status (Eastern Cooperative Oncology Group [ECOG]) 0 or 1 |
||
| 2341 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2342 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2343 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2344 | Have a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 2345 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2346 | Eastern Cooperative Oncology Group performance status of 0 to1. For LM patients, 0 to 2 is acceptable. |
||
| 2347 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2348 | Eastern Cooperative Oncology Group (ECOG) performance status score 0-1 |
||
| 2349 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 within 30 days of signing informed consent |
||
| 2350 | Eastern Cooperative Oncology Group (ECOG) performance status < or equal 2 |
||
| 2351 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status of ‘0-2’ |
||
| 2352 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2353 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 2354 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2355 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2356 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2357 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2358 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Status |
||
| 2359 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2360 | Must have an Eastern Cooperative Oncology Group Performance Status score of 0, 1, or 2 |
||
| 2361 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2362 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2363 | Eastern Cooperative Oncology Group (ECOG) Performance status 0 or 1. |
||
| 2364 | Eastern Cooperative Oncology Group (ECOG) ? 1 |
||
| 2365 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2366 | Have a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 2367 | Subjects with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 2368 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2369 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 2370 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2371 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2372 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of ? 3 (? 2 during dose escalation) |
||
| 2373 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2374 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2375 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2376 | Eastern Cooperative Oncology Group (ECOG) Performance status ? 2. |
||
| 2377 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2378 | Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 |
||
| 2379 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2380 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2381 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2382 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 (Karnofsky > 50%) |
||
| 2383 | Patient must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2384 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 2385 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2386 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2387 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 1 within 14 days prior to study registration |
||
| 2388 | Eastern Cooperative Oncology Group (ECOG)/Zubrod =< 2 |
||
| 2389 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 2390 | Eastern Cooperative Oncology Group [ECOG] 0-2 |
||
| 2391 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2392 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2393 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 (Karnofsky >= 60%) |
||
| 2394 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2395 | Eastern Cooperative Oncology Group (ECOG) performance score of less than equal to (</=) 1 |
||
| 2396 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2397 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2398 | Eastern Co-Operative Group (ECOG) performance status = 0 - 2 |
||
| 2399 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 2400 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2401 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2402 | Eastern Cooperative Oncology Group (ECOG) performance status between 0-2 |
||
| 2403 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to (</=) 1 |
||
| 2404 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2405 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2406 | Participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2407 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2408 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2409 | Have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2410 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2411 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 2412 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1 |
||
| 2413 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2414 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 2415 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 2416 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 2417 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2418 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 2419 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 2420 | Performance Status of Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2421 | Performance status 0-2 (Per Eastern Cooperative Oncology Group (ECOG) criteria) |
||
| 2422 | Eastern Cooperative Oncology Group (ECOG) performance 0-2 |
||
| 2423 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 2424 | Patients must have Eastern Cooperative Oncology Group (ECOG) Performance Status ? 2. |
||
| 2425 | Have a performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2426 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 2427 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 at trial entry |
||
| 2428 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2429 | Easter Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2430 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2431 | Eastern Cooperative Oncology Group (ECOG) performance status: |
||
| 2432 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2433 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2434 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2435 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2436 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky or Lansky score >= 60 |
||
| 2437 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2438 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2439 | Eastern Cooperative Oncology Group (ECOG)/ Zubrod performance status of 0-1. |
||
| 2440 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2441 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2442 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 |
||
| 2443 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2444 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2445 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2446 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2447 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2448 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2449 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2450 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 2451 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2452 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2453 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2454 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2455 | Eastern Cooperative Oncology Group (ECOG) performance status score 0-1 |
||
| 2456 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) with no deterioration over the previous 2 weeks |
||
| 2457 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2458 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2459 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2460 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 at enrollment of this study |
||
| 2461 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 2462 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2463 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2464 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2465 | Have a performance status ?1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 2466 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2467 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 2468 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2469 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 2470 | Eastern Cooperative Oncology Group (ECOG) Performance Status ?1 |
||
| 2471 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2472 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2473 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2474 | Eastern Cooperative Oncology Group (ECOG) performance status of 0–1 (Karnofsky >= 80%) |
||
| 2475 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2476 | Subjects must have ECOG (Eastern Cooperative Oncology Group performance Status of 0 or 1 |
||
| 2477 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 to 1. |
||
| 2478 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2479 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2480 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2481 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2482 | Eastern Cooperative Oncology Group 0 or 1 |
||
| 2483 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2484 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2485 | Has an Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 2486 | Eastern Cooperative Oncology Group (ECOG) performance of 0-2 with anticipated life expectancy of >= 12 weeks |
||
| 2487 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 2488 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2489 | Particiapant has an Eastern Cancer Oncology Group (ECOG) performance status of 0 to 1. |
||
| 2490 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2491 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2492 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 as long as patients are eligible to receive chemotherapy along with concurrent radiotherapy |
||
| 2493 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2494 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2495 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 |
||
| 2496 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2497 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2498 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2499 | Eastern Cooperative Oncology Group (ECOG) performance scale status of 0 or 1 |
||
| 2500 | Performance status of Eastern Cooperative Oncology Group (ECOG) of 0-1 |
||
| 2501 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2502 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2503 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2504 | Patients must have a performance status score of 0, 1 or 2 by Eastern Cooperative Group (ECOG) criteria. |
||
| 2505 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-2 |
||
| 2506 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of ?1. |
||
| 2507 | Eastern Cooperative Oncology Group performance status of 0 or 1 . |
||
| 2508 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2509 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2510 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2511 | Performance status 0-1 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 2512 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2513 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2514 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2515 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. Patients with performance status 2 are only eligible if the decline in performance status is due to metastatic prostate cancer. |
||
| 2516 | The participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2517 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 2518 | Patients who have received one prior regimen must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2519 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2520 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2521 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2522 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2523 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 2524 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 2525 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 1 |
||
| 2526 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2527 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 2528 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 2529 | Eastern Cooperative Oncology Group (ECOG) performance status >= 2 |
||
| 2530 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2531 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2532 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2533 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2534 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 2535 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 2536 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2537 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2538 | Subject has an Eastern Cooperative Oncology Group ( ECOG) performance status of 0-1. |
||
| 2539 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2540 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 2541 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2542 | Eastern Cooperative Oncology Group (ECOG) performance score of 0, 1 |
||
| 2543 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2544 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2545 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2546 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2547 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2548 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2549 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2550 | Eastern Cooperative Oncology Group (ECOG) performance status score ? 2 |
||
| 2551 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2552 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2553 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2554 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 2555 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2556 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2557 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2558 | Eastern Cooperative Oncology Group (ECOG) performance status grade 0, 1, or 2 |
||
| 2559 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2560 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2561 | Have a performance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2562 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 (Karnofsky >= 60%) within 28 days prior to registration |
||
| 2563 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 80%) |
||
| 2564 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2565 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2566 | Eastern Cooperative Oncology Group (ECOG) performance status of 1 or better |
||
| 2567 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2568 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 2569 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2570 | Eastern cooperative oncology group (ECOG) performance status ? 2. |
||
| 2571 | Have a performance status of < 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2572 | Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status; |
||
| 2573 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2574 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2575 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 2576 | Eastern Cooperative Oncology Group performance status 0-1 at time of informed consent |
||
| 2577 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 2578 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 2579 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2580 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2581 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 2582 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2583 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2584 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 2585 | Have a performance status of =< 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 2586 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky >= 70%) |
||
| 2587 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2588 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2589 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2590 | Eastern Cooperative Oncology Group (ECOG) performance status 0 -1 |
||
| 2591 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2592 | Patients have an Eastern Cooperative Oncology Group (ECOG)-specified performance status of =< 3 |
||
| 2593 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2594 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 study entry |
||
| 2595 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2596 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 2597 | Eastern Cooperative Oncology Group performance score of 0 or 1 |
||
| 2598 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2599 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2600 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 2601 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2602 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2603 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 2604 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status: ECOG of 0 or 1 including patients who are not surgical candidates due to comorbid conditions |
||
| 2605 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2606 | Must have a radiographically or clinically evaluable solid tumor Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2607 | Participant must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2608 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1; ECOG 2 allowed if due to bone disease |
||
| 2609 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 2610 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2611 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2612 | Eastern Cooperative Oncology Group performance score (ECOG) ? 2 |
||
| 2613 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 or better |
||
| 2614 | Eastern Cooperative Oncology Group (ECOG) performance status of ?2. |
||
| 2615 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2616 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2 |
||
| 2617 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2618 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2619 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2. |
||
| 2620 | Patients must have a performance status of 0 to 1 according to the Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 2621 | The patient has Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2622 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1 |
||
| 2623 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (or Karnofsky >= 60%) |
||
| 2624 | Subject must have an Eastern Cooperative Oncology Group performance score of equal to or less than 2 |
||
| 2625 | Eastern Cooperative Oncology Group (ECOG) performance status less than 2 |
||
| 2626 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2627 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 2628 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to (</=) 1 |
||
| 2629 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2630 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2631 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to (<=) 2 |
||
| 2632 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2633 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 2634 | Eastern Cooperative Oncology Group (ECOG) performance status assessment of 0 or 1 |
||
| 2635 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2636 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2637 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2638 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2639 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (2 is allowed only if due to bone pain) |
||
| 2640 | Men and women ? 18 years of age with an Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 2641 | Performance status (Eastern Cooperative Oncology Group [ECOG]) 0-2 |
||
| 2642 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2643 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2644 | Subject's Eastern Cooperative Group (ECOG) performance status is 0 or 1; |
||
| 2645 | Eastern Cooperative Oncology Group performance status 0 - 2 |
||
| 2646 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2647 | Have Eastern Cooperative Oncology Group (ECOG) performance status ?2. |
||
| 2648 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 2649 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2650 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 2651 | Must have an Eastern Cooperative Oncology Group Performance Status score of 0, 1, or 2 |
||
| 2652 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2653 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2654 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2655 | Eastern Cooperative Oncology Group performance status =< 2 |
||
| 2656 | Eastern Cooperative Oncology Group (ECOG) Performance status of 0 or 1 |
||
| 2657 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2658 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2659 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 (Karnofsky > 60%) |
||
| 2660 | Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2; if ECOG 2, they must also have a Charlson comorbidity index of =< 5 |
||
| 2661 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1 |
||
| 2662 | PHASE I: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2663 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2664 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 -1 |
||
| 2665 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2666 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2667 | Eastern Cooperative Oncology Group (ECOG) Performance Status ?2. |
||
| 2668 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2669 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2670 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 2671 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2672 | Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of '0-1' at screening visit |
||
| 2673 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 2674 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2675 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2676 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2677 | Eastern Cooperative Oncology Group (ECOG) performance score =< 2 |
||
| 2678 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2679 | Eastern Cooperative Oncology Group (ECOG) performance score of less than or equal to (</=) 1 |
||
| 2680 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 (corresponds to Karnofsky Performance Status [KPS] ? 60%) |
||
| 2681 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 2682 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2683 | Must have Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2684 | Have a Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2685 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2686 | Have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2687 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2688 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at screening. |
||
| 2689 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 2690 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 50%) |
||
| 2691 | Eastern Cooperative Oncology Group performance status grade 0 or 1 |
||
| 2692 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 with no deterioration over the previous 2 weeks. |
||
| 2693 | A life expectancy of at least 3 months and Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2694 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to (</=) 1 |
||
| 2695 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 2696 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2697 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2698 | The Eastern Cooperative Oncology Group (ECOG) performance status must be 0, 1, or 2. |
||
| 2699 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2700 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2701 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2702 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 |
||
| 2703 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 2704 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-1, and life expectancy >= 3 years |
||
| 2705 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 2706 | Patient has Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2707 | Eastern Cooperative Oncology Group (ECOG) performance status: 0, 1 or 2. |
||
| 2708 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2709 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 2710 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2711 | Eastern Cooperative Oncology Group (ECOG) performance status < 2. |
||
| 2712 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky performance score [KPS] >= 70). |
||
| 2713 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2714 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 2715 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2716 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 2717 | Eastern Cooperative Oncology Group (ECOG) status of 0 to 1 |
||
| 2718 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2719 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1. |
||
| 2720 | Eastern Cooperative Oncology Group performance status of ? 1 |
||
| 2721 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2722 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2723 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2724 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2725 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2726 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2727 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2728 | Eastern Cooperative Oncology Group Performance Status 0 or 1 |
||
| 2729 | Eastern Cooperative Oncology Group performance status 0 - 2 |
||
| 2730 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 at the trial entry and an estimated life expectancy of at least 3 months |
||
| 2731 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 2732 | PART B: Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2733 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2734 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2735 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status 0 - 2 |
||
| 2736 | Eastern Cooperative Oncology Group (ECOG) performance scale 0-2 |
||
| 2737 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status 0 – 2 |
||
| 2738 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 2739 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2740 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1 or a Karnofsky performance scale (KP) >= 70% |
||
| 2741 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky >= 70%) |
||
| 2742 | Eastern Cooperative Oncology Group (ECOG) performance status of at least 2 |
||
| 2743 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2744 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2745 | Patients must have a Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2746 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2747 | Eastern Cooperative Oncology Group performance status =< 2 |
||
| 2748 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2749 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2750 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2751 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2752 | Eastern Cooperative Oncology Group (ECOG) performance status of 0–1 (Karnofsky >= 80%) |
||
| 2753 | Eastern Cooperative Oncology Group performance status less than or equal to 2 |
||
| 2754 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2755 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2756 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 80%) |
||
| 2757 | Eastern Cooperative Oncology Group performance status =< 1 |
||
| 2758 | Eastern Cooperative Oncology Group performance status grade of 0, 1, or 2 |
||
| 2759 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2760 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2761 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2762 | Eastern Cooperative Oncology Group (ECOG)performance status of 0 to 2 |
||
| 2763 | Participants must have a performance status of 0-2 based on Eastern Cooperative Oncology Group (ECOG) criteria; participants with a poor performance status (3-4) based solely on bone pain will be eligible, provided there is documentation to verify this |
||
| 2764 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2765 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2766 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2767 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2768 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 2769 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2770 | Eastern Cooperative Oncology Group (ECOG) Performance Status ? 1. |
||
| 2771 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2772 | Eastern Cooperative Oncology Group (ECOG) performance status being 0-1 |
||
| 2773 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2774 | Eastern Cooperative Oncology Group performance status of 0-2 |
||
| 2775 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2776 | Eastern Cooperative Oncology Group performance status 0-2 |
||
| 2777 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2778 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 2779 | Patient must have Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2780 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 and life expectancy > 12 weeks |
||
| 2781 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 2782 | Eastern Cooperative Oncology Group (ECOG)-performance status of 0 or 1 are eligible |
||
| 2783 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2784 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2785 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2786 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2787 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2788 | Eastern Cooperative Oncology Group (ECOG) performance score less than or equal to 1 |
||
| 2789 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 (Karnofsky ?60%). |
||
| 2790 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2791 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2792 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2793 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2794 | PRE-REGISTRATION INCLUSION CRITERIA: Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2795 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 |
||
| 2796 | An Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 is required |
||
| 2797 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2798 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2799 | Eastern Cooperative Oncology Group (ECOG)Performance Status ? 1. |
||
| 2800 | Eastern Cooperative Oncology Group Performance Status of 0 or 1. |
||
| 2801 | Eastern Cooperative Oncology Group (ECOG) performance status is 0-1 |
||
| 2802 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2803 | Eastern Cooperative Oncology Group (ECOG) score of 0 to 2; |
||
| 2804 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2805 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2806 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2807 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 50%) |
||
| 2808 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2809 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2810 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2811 | Performance status (Eastern Cooperative Oncology Group [ECOG]) 0 or 1 |
||
| 2812 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2813 | Karnofsky performance status (KPS) >= 70 or Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 2814 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2815 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2816 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2817 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2818 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 2819 | Eastern Cooperative Oncology Group (ECOG) performance status score of ? 1 at study entry |
||
| 2820 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2821 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2822 | STEP 2 ENROLLMENT AND RANDOMIZATION: the patient’s Eastern Cooperative Oncology Group (ECOG) performance status is =< 2 at study entry |
||
| 2823 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2824 | Eastern co-operative oncology group (ECOG) performance score <= 2 at screening. |
||
| 2825 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 at study entry |
||
| 2826 | Patients must have an Eastern Cooperative Oncology Group (ECOG) status of 0 to 2 |
||
| 2827 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2828 | Patients must have a performance status of 0-2 by Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 2829 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2830 | Eastern Cooperative Oncology Group (ECOG) status 0-1. |
||
| 2831 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2832 | Eastern Cooperative Oncology Group (ECOG) Performance Status <2 |
||
| 2833 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2834 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2835 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 2836 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2837 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2838 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 |
||
| 2839 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1. |
||
| 2840 | Karnofsky (>= 16 years old) >= 70 or Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2841 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky =< 60%) |
||
| 2842 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2843 | Eastern Cooperative Oncology Group (ECOG) performance score of less than or equal to (</=) 1 |
||
| 2844 | Patients must have a performance status of 0 to 2 according to the Eastern Cooperative Oncology Group (ECOG) criteria |
||
| 2845 | Eastern Cooperative Oncology Group (ECOG) performance status = 0 or Karnofsky performance status equivalent |
||
| 2846 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1. |
||
| 2847 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2848 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2849 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2850 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 |
||
| 2851 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2852 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 2853 | Have performance status equal to or less than 2 on Eastern Cooperative Oncology Group (ECOG) scale |
||
| 2854 | ECOG performance status ? 2 (ECOG: Eastern Cooperative Oncology Group) |
||
| 2855 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1 or 2 |
||
| 2856 | Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 2857 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2858 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2859 | Performance status: Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2860 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2861 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2862 | Eastern Cooperative Oncology Group (ECOG) performance status (Zubrod) ?2 |
||
| 2863 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2864 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale is required |
||
| 2865 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2866 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2867 | Zubrod/Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2868 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2869 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky > 50%) |
||
| 2870 | Eastern Cooperative Oncology Group (ECOG) performance status (0-2) |
||
| 2871 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2872 | Eastern Cooperative Oncology Group Performance Status score of 0 or 1 |
||
| 2873 | Adequate performance status (Eastern Cooperative Oncology Group [ECOG] 0, 1) |
||
| 2874 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 2875 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2876 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%; Lansky score >= 50) |
||
| 2877 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2878 | Patients with Eastern Cooperative Oncology Group (ECOG)-performance status of 0 or 1 are eligible |
||
| 2879 | Eastern Cooperative Oncology Group (ECOG) performance status </= 2. |
||
| 2880 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 for ages >= 16 or Lansky play >= 80% for ages =< 15 |
||
| 2881 | The participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2882 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2883 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2884 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2885 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2886 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2887 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2888 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2889 | Karnofsky performance status >= 70% or Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 2890 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 2891 | Patients with Eastern Cooperative Oncology Group (ECOG) 0-1 are eligible |
||
| 2892 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2893 | Patient Eastern Cooperative Oncology Group (ECOG) performance status: 0-1 |
||
| 2894 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2895 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2896 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 2897 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2898 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2899 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 at study entry |
||
| 2900 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2901 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2902 | Maintain a performance status score of 0 to 2 according to the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 2903 | Karnofsky performance status greater than or equal to 80% or Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 2904 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2905 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2906 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2907 | Eastern Cooperative Oncology Group (ECOG) Performance Score of 0-2. |
||
| 2908 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2909 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 2910 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 2911 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2912 | World Health Organisation (WHO) or Eastern Cooperative Oncology Group (ECOG) Performance status 0-2. |
||
| 2913 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2914 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 are eligible |
||
| 2915 | Performance score of at least 80% by Karnofsky or 0 to 2 Eastern Cooperative Oncology Group (ECOG) |
||
| 2916 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1 |
||
| 2917 | Eastern Cooperative oncology group performance status 0-2 |
||
| 2918 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 2919 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 2920 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, or 1 |
||
| 2921 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 2922 | Eastern Cooperative Oncology Group (ECOG) performance status determined to be between 0 and 3 |
||
| 2923 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 2924 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 2925 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2926 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2927 | Eastern Cooperative Oncology Group performance status less than 2. |
||
| 2928 | Performance status of Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 2929 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 2930 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 2931 | Easter Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 2932 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2933 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2934 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2935 | The Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) performance status of 2-3.or patients with chronic lymphocytic leukemia requiring treatment age >65 years at the time of signing informed consent and ECOG/WHO performance status of 0-1 and a CIRS or Charlson co-morbidity score of 2 or higher. |
||
| 2936 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2937 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2938 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 2939 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 2940 | Performance status: Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 2941 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2942 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2943 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 or greater, based on treating physician's discretion |
||
| 2944 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2945 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2946 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or Karnofsky performance status >= 60% |
||
| 2947 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 at screening |
||
| 2948 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2949 | Eastern Cooperative Oncology Group Performance Status: 0 or 1 |
||
| 2950 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 2951 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 2952 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2953 | Eastern Cooperative Oncology Group (ECOG) performance score < 2 and life expectancy of at least 4 months |
||
| 2954 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 2955 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2; |
||
| 2956 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 2957 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance score less than or equal to 1. |
||
| 2958 | Eastern Cooperative Oncology Group (ECOG) performance score of 0, 1, or 2 |
||
| 2959 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2960 | Performance status of 0-1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale and life expectancy > 3 months |
||
| 2961 | E 06. Eastern Cooperative Oncology Group (ECOG) performance status >2. |
||
| 2962 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2963 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2964 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 60%) |
||
| 2965 | Eastern Cooperative Oncology Group (ECOG) =< 2 or Karnofsky >= 70 |
||
| 2966 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 2967 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 2 |
||
| 2968 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 60%) |
||
| 2969 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky performance status >= 60%) |
||
| 2970 | The Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2971 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2972 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2973 | Have an Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 2974 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 2975 | Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status =< 2 |
||
| 2976 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 2977 | Have a performance status of equal to or less than 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 2978 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 2979 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 2980 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2981 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 2982 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2983 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2984 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1, or 2 |
||
| 2985 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%, Lansky >= 50%) |
||
| 2986 | Performance status 0-2 (Eastern Cooperative Oncology Group [ECOG]) |
||
| 2987 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 2988 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) less than or equal to 1 |
||
| 2989 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 2990 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2991 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2992 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 2993 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 2994 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 2995 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 2996 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 (Karnofsky >= 60%) |
||
| 2997 | Eastern Cooperative Oncology Group (ECOG) or Zubrod performance status of 0-1 within 30 days prior to registration |
||
| 2998 | Eastern Cooperative Group (ECOG) performance status of 0 to 1 |
||
| 2999 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3000 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (or Karnofsky >= 70%) |
||
| 3001 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 3002 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3003 | The participant has a Eastern Cooperative Oncology Group (ECOG) performance status ?1. |
||
| 3004 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3005 | Eastern Cooperative Oncology Group performance status 0 to 2. |
||
| 3006 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3007 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3008 | Has Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3009 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3010 | Patients must have Eastern Cooperative Oncology Group (ECOG) Performance Status ?2. |
||
| 3011 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 performed within 10 days of treatment initiation. |
||
| 3012 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3013 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3014 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 3015 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3016 | Have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (see Appendix 14.3) |
||
| 3017 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3018 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3019 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3020 | Eastern Cooperative Oncology Group (ECOG) score 2 or |
||
| 3021 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3022 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 within 14 days prior to registration |
||
| 3023 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3024 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky > 60%) |
||
| 3025 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3026 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3027 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3028 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3029 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 3030 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3031 | Performance status Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 3032 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 with a greater than nine week life expectancy |
||
| 3033 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 60%) |
||
| 3034 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3035 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3036 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3037 | Eastern Cooperative Oncology Group (ECOG) performance status 0 |
||
| 3038 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3039 | Eastern Cooperative Oncology Group (ECOG) performance 0-2 |
||
| 3040 | Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 |
||
| 3041 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 3042 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3043 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3044 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 for adults, Karnofsky performance status >= 50% for pediatric patients > 10 years of age, and Lansky performance status >= 50 for pediatric patients =< 10 years of age |
||
| 3045 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3046 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3047 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3048 | Must have an Eastern Cooperative Oncology Group (ECOG) performance status score of ?2. |
||
| 3049 | Performance Status (Eastern Cooperative Oncology Group [ECOG]) less than or equal to 3 |
||
| 3050 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 2 |
||
| 3051 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 |
||
| 3052 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3053 | Karnofsky score >= 70 or Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 3054 | Eastern Cooperative Oncology Group (ECOG) performance status equal to 0, 1, or 2, and Karnofsky performance status greater than or equal to 60% |
||
| 3055 | Karnofsky performance status >= 70% (Eastern Cooperative Oncology Group [ECOG] performance status 0-1) |
||
| 3056 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3057 | Eastern Cooperative Oncology Group (ECOG) <= 1 |
||
| 3058 | Eastern Cooperative Oncology Group (ECOG) performance status: 0-2 |
||
| 3059 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 and Karnofsky >= 60% |
||
| 3060 | Easter Cooperative Oncology Group (ECOG) performance status of 0,1,or 2 |
||
| 3061 | Eastern Cooperative Oncology Group (ECOG) performance of 0-2 |
||
| 3062 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 3063 | Subject has Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3064 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 3065 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3066 | Eastern Cooperative Oncology Group Status of 0 or 1 |
||
| 3067 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 at screening |
||
| 3068 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3069 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3. |
||
| 3070 | Eastern Cooperative Oncology Group (ECOG) performance status ?2. |
||
| 3071 | Eastern Cooperative Oncology Group (ECOG) score of ? 2 |
||
| 3072 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 10 days prior to registration for protocol therapy |
||
| 3073 | Eastern Cooperative Oncology Group Performance Status of 0 to 2 |
||
| 3074 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3075 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 at the time of screening and enrollment |
||
| 3076 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 2. |
||
| 3077 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3078 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3079 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3080 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3081 | Eastern Cooperative Oncology Group (ECOG) performance status: Part 1: 0-2, Part 2: 0-1 |
||
| 3082 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3083 | Has an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3084 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 3085 | Karnofsky performance status (KPS) >= 70%, Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 3086 | Eastern Cooperative Oncology Group (ECOG) score between 0-1 |
||
| 3087 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3088 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 within 28 days prior to registration. |
||
| 3089 | Eastern Cooperative Oncology Group (ECOG) performance status between 0 and 2 at the time of screening |
||
| 3090 | Eastern Cooperative Oncology Group 0 or 1 |
||
| 3091 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2; |
||
| 3092 | Subject has Eastern Cooperative Oncology Group Performance Status of 0 or 1 |
||
| 3093 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1 |
||
| 3094 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3095 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, 2, or 3. |
||
| 3096 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3097 | Eastern Cooperative Oncology Group (ECOG) performance status of <= 1. (ECOG performance status of 0 or 1). |
||
| 3098 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3099 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3100 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3101 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%) |
||
| 3102 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3103 | Subject has Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3104 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3105 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3106 | Eastern Cooperative Oncology Group (ECOG) Performance status ?2 |
||
| 3107 | Must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, adequate organ function, and a life expectancy of ? 3 months |
||
| 3108 | Eastern Cooperative Oncology Group (ECOG) status 0 – 2 |
||
| 3109 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 3110 | Eastern cooperative oncology group (ECOG) performance status =< 2 (Karnofsky performance status > 70%) |
||
| 3111 | Eastern Cooperative Oncology Group (ECOG) Performance Status ?1 |
||
| 3112 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2. |
||
| 3113 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3114 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3115 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3116 | Eastern Cooperative Oncology Group status of 0 or 1 |
||
| 3117 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3118 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3119 | Subject has Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 2 at screening. |
||
| 3120 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3121 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3122 | Eastern Cooperative Oncology Group (ECOG) 0 to 2 |
||
| 3123 | ECOG (Eastern Cooperative Oncology Group) performance status of ? 2 |
||
| 3124 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3125 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 3126 | Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 or 1. |
||
| 3127 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 at screening. |
||
| 3128 | Subjects must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3129 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3130 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3131 | Patient must have a Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3132 | Eastern Cooperative Oncology Group (ECOG) Performance Status ? 1. |
||
| 3133 | Has Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 3134 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3135 | Have Eastern Cooperative Oncology Group (ECOG) performance status score 0-2 |
||
| 3136 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 3137 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3138 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3139 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3140 | Life expectancy - =/> 3 months, Eastern Cooperative Oncology Group status = 0 or 1. |
||
| 3141 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 3142 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3143 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3144 | Eastern Cooperative Oncology Group (ECOG) performance 0, 1, or 2 |
||
| 3145 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 (corresponds to Karnofsky Performance Status [KPS] ?60%) |
||
| 3146 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3147 | Eastern Cooperative Oncology Group (ECOG) score of 0-1 |
||
| 3148 | Patients with Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3149 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3150 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3151 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3152 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3153 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2. |
||
| 3154 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (corresponds to Karnofsky performance status [KPS of >= 70) |
||
| 3155 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3156 | Eastern Cooperative Oncology Group (ECOG) performance < 4 |
||
| 3157 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3158 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3159 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ?2. |
||
| 3160 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3161 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 3162 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3163 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 14 days before enrollment. |
||
| 3164 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 14 days before enrollment. |
||
| 3165 | Eastern Cooperative Oncology Group (ECOG) performance status between 0 and 2 |
||
| 3166 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 3167 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3168 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 60%) |
||
| 3169 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 3170 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3171 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3172 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 1 |
||
| 3173 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3174 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 |
||
| 3175 | Eastern Cooperative Oncology Group (ECOG) Status 0-2 |
||
| 3176 | Eastern Cooperative Oncology Group (ECOG) ? 2 or a Karnofsky Performance Status (KPS) ? 60%. |
||
| 3177 | Performance status 0-2 by Eastern Cooperative Oncology Group criteria |
||
| 3178 | Eastern Cooperative Oncology Growth (ECOG) performance status =< 2 |
||
| 3179 | Patients must have an Eastern Cooperative Oncology Group (ECOG) score =< 3 |
||
| 3180 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3181 | Must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3182 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3183 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3184 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3185 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3186 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3187 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3188 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 3189 | Karnofsky performance status/Eastern Cooperative Oncology Group (ECOG) performance status >= 70/2 |
||
| 3190 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3191 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 3192 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 (Karnofsky >= 60%) |
||
| 3193 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 3194 | Eastern Cooperative Oncology Group (ECOG ) 0 or 1 |
||
| 3195 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 1 |
||
| 3196 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. |
||
| 3197 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3198 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3199 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3200 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3201 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3202 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3203 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 3204 | Eastern Cooperative Oncology Group (ECOG) status of 0-2. |
||
| 3205 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3206 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 3207 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 and a life expectancy > 12 weeks. |
||
| 3208 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3209 | Eastern Cooperative Oncology Group (ECOG) performance status score 0-1 |
||
| 3210 | Eastern cooperative group (ECOG) performance status =< 2 |
||
| 3211 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 14 days prior to the initiation of study treatment |
||
| 3212 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 3213 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 |
||
| 3214 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3215 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3216 | ECOG (Eastern Cooperative Oncology Group) performance status of ? 2 |
||
| 3217 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3218 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3219 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3220 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 3221 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 - 2 |
||
| 3222 | Eastern Oncology Cooperative Group (ECOG) Performance Status 0 or 1 |
||
| 3223 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 3224 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 3225 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1, or 2. |
||
| 3226 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 if age less than (<) 71 years; ECOG status of 0 if age 71 to 75 years |
||
| 3227 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3228 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 3229 | Eastern Cooperative Oncology Group (ECOG) performance status > 2 |
||
| 3230 | Eastern Oncology Cooperative Group (ECOG) performance status =< 2 |
||
| 3231 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3232 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3233 | Has a performance status ? 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3234 | Eastern Cooperative Oncology Group (ECOG) performance status measure will be used; (ECOG performance status less than or equal to 3) |
||
| 3235 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky >= 70%) |
||
| 3236 | Patients must have an Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status of 0-2 |
||
| 3237 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 within 14 days of study entry |
||
| 3238 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3239 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 |
||
| 3240 | Eastern Cooperative Oncology Group performance status less than or equal to 2. |
||
| 3241 | Eastern Cooperative Oncology Group (ECOG) 0 to 1 |
||
| 3242 | Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 will be eligible |
||
| 3243 | Eastern Cooperative Oncology Group performance status of 0 or 1 |
||
| 3244 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 1 |
||
| 3245 | Eastern Cooperative Oncology Group (ECOG) performance statue 0 to 2 |
||
| 3246 | Eastern cooperative oncology group (ECOG) performance status 0 or 1 |
||
| 3247 | SCREENING: Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3248 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 3249 | Adequate performance status for the study, Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 3250 | Has an Eastern Cooperative Oncology Group (ECOG) score of 0-1, with a life expectancy of >3 months; |
||
| 3251 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 2 |
||
| 3252 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 3253 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3254 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance score (KPS) >= 50% |
||
| 3255 | Subject can move around on their own, has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and has an estimated life expectancy of at least 3 months |
||
| 3256 | Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (</=) 2; |
||
| 3257 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 3258 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3259 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3260 | Patient with an Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3261 | Has performance status Grade >2 (Eastern Cooperative Oncology Group [ECOG] criteria). |
||
| 3262 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3263 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 3264 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 3265 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3266 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3267 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3268 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3269 | Eastern Cooperative Group (ECOG) performance status of 0 or 1 |
||
| 3270 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3271 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3272 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3273 | Performance status: Karnofsky score >= 70 or Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3274 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3275 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3276 | Eastern Cooperative Oncology Group performance score of 0 or 1 |
||
| 3277 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3278 | Karnofsky performance status (KPS) >= 60; Eastern Cooperative Oncology Group (ECOG) 0, 1, or 2 |
||
| 3279 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3280 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3281 | Eastern Cooperative Oncology Group (ECOG) Performance status of 0 or 1. |
||
| 3282 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 3283 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3284 | Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 3285 | Patients must have a Eastern Cooperative Oncology Group status of </=2. |
||
| 3286 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3287 | Eastern Cooperative Oncology Group (ECOG) Performance Status =< 2 |
||
| 3288 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3289 | Eastern Clinical Oncology Group performance status =< 2 (Karnofsky >= 60%) |
||
| 3290 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 (Karnofsky performance status [KPS] >= 50) |
||
| 3291 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3292 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 3293 | Patient must have an Eastern Cooperative Oncology Group (ECOG)/Zubrod status of 0-1 |
||
| 3294 | Eastern cooperative group (ECOG) performance status =< 2 |
||
| 3295 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3296 | Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less. |
||
| 3297 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3298 | Performance status Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3299 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 in Parts 1 and 2 dose escalation and titration, and 0, 1, 2 in Part 3 dose expansion |
||
| 3300 | Eastern Cooperative Oncology Group status of 0 or 1 |
||
| 3301 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3302 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 3303 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3304 | Have a performance status of ? 2 on the Eastern Cooperative Oncology Group (ECOG) scale in Part A and ? 1 on the ECOG scale in Part B. |
||
| 3305 | Eastern Cooperative Oncology Group performance status 0 or 1. |
||
| 3306 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3307 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3308 | Eastern Cooperative Oncology Group Performance Status 0, 1 or 2 |
||
| 3309 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 14 days prior to dose 1 of mirvetuximab soravtansine |
||
| 3310 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3311 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 3312 | Eastern Cooperative Oncology Group (ECOG) performance status of 0; |
||
| 3313 | Eastern Cooperative Oncology Group performance status of 0 -2 |
||
| 3314 | An Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2. |
||
| 3315 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3316 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3317 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3318 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3319 | Eastern Cooperative Oncology Group Performance Status score equal to or less than (<=) 2 |
||
| 3320 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3321 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3322 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3323 | Eastern Cooperative Oncology Group (ECOG)-performance status of 0 or 1 are eligible |
||
| 3324 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3325 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3326 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3327 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3328 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3329 | Eastern Cooperative Oncology Group (ECOG) performance status </= 2 |
||
| 3330 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3331 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3332 | Patient must have an Eastern Cooperative Oncology Group (ECOG) Performance Score of 0, 1, or 2 |
||
| 3333 | Eastern Cooperative Oncology Group (ECOG) performance status of equal or less than 3 at study entry |
||
| 3334 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3335 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3336 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3337 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 at study entry |
||
| 3338 | Eastern Cooperative Oncology Group (ECOG) Performance Status >2 |
||
| 3339 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3340 | Eastern Cooperative Oncology Group (ECOG) performance status of <= 2 |
||
| 3341 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3342 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. |
||
| 3343 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3344 | Eastern Cooperative Oncology Group (ECOG) performance status 0 – 2 |
||
| 3345 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky > 70%) |
||
| 3346 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3347 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3348 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3349 | Performance status 0-1 (Eastern Cooperative Oncology Group classification); |
||
| 3350 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3351 | Eastern cooperative oncology group (ECOG) performance status 0 or 1 |
||
| 3352 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3353 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3354 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1; life expectancy at least 3 months |
||
| 3355 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 or Karnofsky performance status ? 70 |
||
| 3356 | Male or female of >=18 years of age with the Eastern Cooperative Oncology Group (ECOG) performance status 0-1, Child-Pugh score of 5-7, and Life expectancy of 3 months or greater. |
||
| 3357 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3358 | ECOG (Eastern Cooperative Oncology Group) performance status ? 1 (Karnofsky ? 70%). |
||
| 3359 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3360 | An Eastern Cooperative Oncology Group (ECOG) (Eastern Cooperative Oncology Group) performance status of 0, 1, or 2 or a KPS (Karnofsky performance score) of at least 60, prior to surgery |
||
| 3361 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3362 | Patients must have an Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status of 0-2 |
||
| 3363 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 3364 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 3365 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3366 | Subject must have an Eastern Cooperative Oncology Group (ECOG) performance status ? 1. |
||
| 3367 | European Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3368 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3369 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3370 | Performance status of 0-2 based on the Eastern Cooperative Oncology Group (ECOG) criteria; patients with performance status 3 or 4, based solely on bone pain, are also eligible, provided that there is a source document to verify this |
||
| 3371 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 3372 | Eastern Cooperative Oncology Group (ECOG) performance status <=2 (corresponds to Karnofsky Performance Status [KPS] >=60%) |
||
| 3373 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3374 | Eastern Cooperative Oncology Group (ECOG) performance status >1. |
||
| 3375 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 at baseline; |
||
| 3376 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3377 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3378 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3379 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status of ‘0-2’ |
||
| 3380 | ECOG (Eastern Cooperative Oncology Group) performance score of 0 or 1 |
||
| 3381 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3382 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3383 | Eastern Cooperative Oncology Group Performance Status 2. |
||
| 3384 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3385 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 |
||
| 3386 | Eastern cooperative oncology group (ECOG) performance status ? 2 |
||
| 3387 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 3388 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3389 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3390 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3391 | Patient has received a platinum containing regimen. Eastern Cooperative Oncology Group (ECOG) performance status 0-2. Radiographically-documented measureable disease. |
||
| 3392 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3393 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 3394 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3395 | Karnofsky performance status greater than or equal to 70 or Eastern Cooperative Oncology Group (ECOG) performance of 0-2 |
||
| 3396 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 |
||
| 3397 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3398 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3399 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 3400 | Eastern Cooperative Oncology Group (ECOG) performance score 0 or 1 |
||
| 3401 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 3402 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 3403 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ? 1. |
||
| 3404 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3405 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1. ?? 18 years of age. |
||
| 3406 | Eastern Cooperative Oncology Group (ECOG) Performance status of ? 1; ; |
||
| 3407 | Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 3408 | Eastern Cooperative Oncology Group (ECOG) performance status = 1 |
||
| 3409 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3410 | Eastern Cooperative Oncology Group (World Health Organization) performance status of 0 or 1 |
||
| 3411 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2 |
||
| 3412 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3413 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3414 | Eastern Cooperative Oncology Group (ECOG) of 0 or 1 |
||
| 3415 | Eastern Cooperative Oncology Group (ECOG) of 0 or 1 |
||
| 3416 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (Appendix C). |
||
| 3417 | Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1 or 2 |
||
| 3418 | Eastern Cooperative Oncology Group (ECOG) performance status score of =< 3 |
||
| 3419 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3420 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 within 14 days prior to first dose of study drug. |
||
| 3421 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 1 |
||
| 3422 | Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1. NOTE: Subjects with a performance status of 2 can be enrolled if the subject's confinement to bed and inability to carry out work activities is due solely to cancer-related pain, as assessed by the Investigator. |
||
| 3423 | Has an Eastern Cooperative Oncology Group (ECOG) performance status 0-1. |
||
| 3424 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 3425 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3426 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3427 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3428 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2; |
||
| 3429 | Willingness to provide consent for biopsies positive or BRAF WT measurable disease, Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and adequate organ and marrow function |
||
| 3430 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. |
||
| 3431 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 3432 | Subject has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3433 | Eastern Cooperative Oncology Group performance score of 0 or 1 |
||
| 3434 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3435 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 3436 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3437 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3438 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 3439 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1. |
||
| 3440 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 within 14 days prior to first dose of study treatment. |
||
| 3441 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3442 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3443 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3444 | Eastern Cooperative Oncology Group performance status of >1. |
||
| 3445 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3446 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3447 | Eastern Co-operative Oncology Group (ECOG) performance status of 0-2 |
||
| 3448 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3449 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3450 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3451 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3452 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3453 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3454 | Performance Status score of 0 or 1 according to the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 3455 | Eastern CooperativeOncology Group (ECOG) performance status of 0 or 1 |
||
| 3456 | ECOG (Eastern Cooperative Oncology Group) Performance Score of 0 or 1. |
||
| 3457 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3458 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3459 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1, or 2 |
||
| 3460 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 3461 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3462 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3463 | Performance score of at least 80% by Karnofsky or 0 to 2 Eastern Cooperative Oncology Group (ECOG) |
||
| 3464 | Performance status: Eastern Cooperative Oncology Group (ECOG) 2 or less or Karnofsky of at least 60 |
||
| 3465 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 - 2 |
||
| 3466 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3467 | Eastern Cooperative Oncology Group status of 0 or 1 |
||
| 3468 | Eastern Cooperative Oncology Group (ECOG) Performance status 0-1 |
||
| 3469 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 3470 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3471 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3472 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3473 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 for Arm A and C subjects and 0-2 for Arm B. |
||
| 3474 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3475 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 at screening |
||
| 3476 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 3477 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2. |
||
| 3478 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1 or 2 |
||
| 3479 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3480 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 |
||
| 3481 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3482 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 (or a Karnofsky performance status of > 50%) |
||
| 3483 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3484 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3485 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3486 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3487 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 3488 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3489 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 3490 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3491 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3492 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry |
||
| 3493 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3494 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3495 | Eastern Cooperative Oncology Group status of 0 or 1 |
||
| 3496 | Eastern Cooperative Oncology Group status of 2 or lower |
||
| 3497 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 1. |
||
| 3498 | Eastern Cooperative Oncology Group (ECOG) of 0 to 1 |
||
| 3499 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 3500 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 in Part 1 and Part 2, participants enrolled in the extension/tail portion, Part 3 and Part 4 must have an ECOG performance status of 0 or 1 |
||
| 3501 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3502 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 3503 | Patients with a Karnofsky Performance Status of 70% to 100% (or equivalent, Eastern Cooperative Oncology Group [ECOG] performance status of 0 or 1); Performance Status Evaluation), and an anticipated life expectancy of ? 3 months. |
||
| 3504 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 at study entry ECOG, or Karnofsky >= 60% |
||
| 3505 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3506 | Subjects have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3507 | Eastern Cooperative Group (ECOG) score ?2. |
||
| 3508 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3509 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3510 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (Karnofsky > 70%) |
||
| 3511 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3512 | Performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 3513 | Eastern Cooperative Oncology Group performance status score 0 or 1 |
||
| 3514 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3515 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3516 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 3517 | Zubrod (Eastern Cooperative Oncology Group [ECOG]) performance status 0 or 1 |
||
| 3518 | Eastern Cooperative Group (ECOG) performance status of 0-1 |
||
| 3519 | Eastern Cooperative Oncology Group (ECOG)/Zubrod/ Southwest Oncology Group (SWOG) performance status < 2 (Karnofsky performance status >= 70%) |
||
| 3520 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3521 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3522 | Eastern Cooperative Oncology Group (ECOG) performance status 2 or less |
||
| 3523 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 3524 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3525 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3526 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3527 | Eastern Cooperative Oncology Group (ECOG) performance status of >1. |
||
| 3528 | Performance Status: Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3529 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3530 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 3 at study entry |
||
| 3531 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3532 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3533 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 3534 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 1 |
||
| 3535 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3536 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky > 70%) |
||
| 3537 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3538 | Patient’s Eastern Cooperative Oncology Group (ECOG) performance status must be 0, 1 or 2 |
||
| 3539 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3540 | Eastern Cooperative Oncology Group (ECOG) performance status ? 3 for subjects aged > 16 years; Lansky score ? 20 for subjects from birth to 16 years |
||
| 3541 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3542 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 3543 | Patients must have an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1. |
||
| 3544 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3545 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3546 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 3547 | Eastern Cooperative Oncology Group (ECOG) performance status ?1 |
||
| 3548 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1. |
||
| 3549 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3550 | An Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3551 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3552 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3553 | Performance status 0-2 of the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 3554 | Eastern Cooperative Oncology Group (ECOG) Performance status ? 2 |
||
| 3555 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3556 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3557 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3558 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3559 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3560 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3561 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2. |
||
| 3562 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3563 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3564 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3565 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 for run-in phase; ECOG =< 1 for randomized phase |
||
| 3566 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3567 | History/physical examination, including weight and assessment of Eastern Cooperative Oncology Group (ECOG) performance status, within 1 month of registration |
||
| 3568 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3569 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2. |
||
| 3570 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3571 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3572 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 3573 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3574 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3575 | Subject has an Eastern Cooperative Oncology Group (ECOG) =< 2 OR Karnofsky >= 60% performance status |
||
| 3576 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 |
||
| 3577 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3578 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3579 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3580 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3581 | Eastern Cooperative Oncology Group (ECOG) of 0 or 1 |
||
| 3582 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 with greater than 3 month’s life expectancy |
||
| 3583 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 3584 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3585 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky > 50%) |
||
| 3586 | Eastern Cooperative Group (ECOG) status score of <=2. |
||
| 3587 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2 |
||
| 3588 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3589 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3590 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3591 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3592 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky or Lansky score >= 60 |
||
| 3593 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3594 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3595 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 3596 | Eastern Cooperative Oncology Group, performance status of 0, 1 or 2. |
||
| 3597 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 3598 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3599 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3600 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0, 1 or 2. |
||
| 3601 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 3602 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 3603 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3604 | Patients with Eastern Cooperative Oncology Group (ECOG) score of <=2 at the time of screening |
||
| 3605 | Eastern Cooperative Oncology Group (ECOG) performance status equal to or less than 2 |
||
| 3606 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (Karnofsky > 70%) |
||
| 3607 | Performance status of 0, 1 or 2 on the Eastern Cooperative Oncology Group (ECOG) Scale |
||
| 3608 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 2 |
||
| 3609 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3610 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 3611 | Performance status of Eastern Cooperative Oncology Group (ECOG) =< 2 or Karnofsky >= 60%; note: participants with lower performance status based solely on bone pain secondary to multiple myeloma will be eligible |
||
| 3612 | A life expectance of at least 3 months as evidenced by Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3613 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3614 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2; NOTE: For the phase I part of the study, patients with ECOG performance status 2 will be excluded |
||
| 3615 | Have a performance status of less than or equal to 1 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 3616 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 at study entry |
||
| 3617 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 within 14 days of study entry |
||
| 3618 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3619 | Must have Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1. |
||
| 3620 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3621 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3622 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3623 | Eastern Cooperative Oncology Group performance status 0-2 |
||
| 3624 | Eastern Cooperative Oncology Group Performance Status of 0 or 1 for Parts A and B. Subjects with Eastern Cooperative Oncology Group Performance Status of 2 or less may be entered into Part C with approval of medical monitor. |
||
| 3625 | Eastern Cooperative Oncology Group performance status of 0, 1 or 2. |
||
| 3626 | Karnofsky performance status >= 70% or Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 3627 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3628 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 3629 | The subject has an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3630 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky >= 60%) |
||
| 3631 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 or for children < 10 years of age, Lansky of > 50 is required |
||
| 3632 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3633 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 50%) |
||
| 3634 | Eastern Cooperative Oncology Group (ECOG) Performance Status <=2 |
||
| 3635 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3636 | Eastern Cooperative Oncology Group (ECOG) score of 0 or 1. |
||
| 3637 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3638 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3639 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2. |
||
| 3640 | Eastern Cooperative Oncology Group performance status of 0, 1 or 2. |
||
| 3641 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3642 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 3643 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 or Karnofsky performance scale 50-100% |
||
| 3644 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3645 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3646 | Eastern Cooperative Oncology Group Performance Status 0-1 |
||
| 3647 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 |
||
| 3648 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 3649 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 |
||
| 3650 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3651 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to1. |
||
| 3652 | The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3653 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3654 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 3655 | Eastern Cooperative Oncology Group performance status 0-2 |
||
| 3656 | Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status of 0, 1, or 2 (Karnofsky >= 60%) |
||
| 3657 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3658 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3659 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3660 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3661 | Eastern Cooperative Oncology Group (ECOG) performance status score of =< 2 |
||
| 3662 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3663 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 2 |
||
| 3664 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3665 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3666 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3667 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3668 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 - 1 within 30 days of signing informed consent |
||
| 3669 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3670 | Subject has Eastern Cooperative Oncology Group (ECOG) performance status ? 1. |
||
| 3671 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1. Patients with stable ECOG scores of 2 may be allowed with medical monitor approval. |
||
| 3672 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3673 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60) |
||
| 3674 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3675 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3676 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3677 | Eastern Cooperative Oncology Group (ECOG) 0-3 |
||
| 3678 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3679 | Patients with performance status of =< 3 (Eastern Cooperative Oncology Group performance status scale, 3 only allowed if decline in status is deemed related to lymphoma and felt potentially reversible by the treating physician) |
||
| 3680 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3681 | Karnofsky performance status >= 50% or Eastern Cooperative Oncology Group (ECOG) performance score of =< 2 |
||
| 3682 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3683 | Clinical performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3684 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3685 | Eastern Cooperative Oncology Group performance status of =<2 |
||
| 3686 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3687 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3688 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3689 | Eastern Cooperative Oncology Group (ECOG) performance status < 3 |
||
| 3690 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 3691 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3692 | Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) performance status 0-2 |
||
| 3693 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3694 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3695 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3696 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3697 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3698 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3699 | Eastern Cooperative Oncology Group (ECOG) Performance status assessed between 0 and 2; performance status of 3 will be accepted if impairment is caused by DLBCL complications and improvement is expected once therapy is initiated |
||
| 3700 | Have an ECOG (Eastern Cooperative Oncology Group) performance scale status of 0 – 2 |
||
| 3701 | Eastern Cooperative Oncology Group (ECOG) performance status between 0-2 |
||
| 3702 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status 0-1 |
||
| 3703 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3704 | Have Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3705 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3706 | PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 3 (symptomatic and in bed > 50% of the day) |
||
| 3707 | Eastern Cooperative Oncology Group performance status 0-2 |
||
| 3708 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 3 |
||
| 3709 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 3710 | Performance status (Eastern Cooperative Oncology Group [ECOG]) =< 2 |
||
| 3711 | Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of day) |
||
| 3712 | Patient is spending more than 50% of time out of bed on a daily basis, as measured by an Eastern Cooperative Oncology Group (ECOG) performance status rating of level 0, 1, or 2 |
||
| 3713 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3714 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3715 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 3716 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3717 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 |
||
| 3718 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky score > 70% |
||
| 3719 | Adult patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1; pediatric patients must have Lansky score >= 60% |
||
| 3720 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3721 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3722 | Eastern Cooperative Oncology Group (ECOG) performance status less than (<) 2. |
||
| 3723 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3724 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 during dose finding, 0-2 during MTD expansion |
||
| 3725 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3726 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3727 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 performed within 10 days prior to receiving the first dose of study therapy |
||
| 3728 | Participants with an Eastern Cooperative Oncology Group (ECOG) of 0 - 1. |
||
| 3729 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3730 | Eastern Cooperative Oncology Group (ECOG) Performance status ? 2. |
||
| 3731 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3732 | Subject must have an Eastern Cooperative Oncology Group (ECOG) performance score of ?2. |
||
| 3733 | Eastern Cooperative Oncology Group performance status of 0-1 |
||
| 3734 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 and life expectancy of greater than 3 months. |
||
| 3735 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 3736 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 3737 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3738 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 3739 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2. |
||
| 3740 | ECOG (Eastern Cooperative Oncology Group) 0-1 |
||
| 3741 | Have a performance status of 0 to 1 on the Eastern Cooperative Oncology Group scale |
||
| 3742 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3743 | Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of the day) |
||
| 3744 | Eastern Cooperative Group performance status of 0, 1, or 2 |
||
| 3745 | Patients must have a performance status of Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3746 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, 2, 3, or 4 |
||
| 3747 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 3748 | Patients must exhibit an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2. |
||
| 3749 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3750 | PATIENTS: Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower. |
||
| 3751 | At the time of recruitment, a life expectancy of greater than 6 months and/or a Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 |
||
| 3752 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 at time of initial screening |
||
| 3753 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3754 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 3755 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3756 | Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 |
||
| 3757 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3758 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2 |
||
| 3759 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3760 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 3 |
||
| 3761 | Patients are eligible regardless of Eastern Cooperative Oncology Group (ECOG) performance status |
||
| 3762 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3763 | PATIENTS ONLY: Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to 2 |
||
| 3764 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3765 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky or Lansky score >= 60 |
||
| 3766 | Eastern Cooperative Oncology Group (ECOG) performance status between 0 and 3 |
||
| 3767 | Have an Eastern Cooperative Oncology Group performance status of =< 1 |
||
| 3768 | Eastern Cooperative Oncology Group (ECOG) performance score 0-2 at the time of randomization |
||
| 3769 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3770 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3771 | Eastern Cooperative Oncology Group (ECOG) < 3 |
||
| 3772 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 within 28 days prior to initiation of treatment |
||
| 3773 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 3774 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3775 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 3776 | Eastern Cooperative Oncology Group (ECOG) performance status of 0?2 |
||
| 3777 | Eastern Cooperative Oncology Group (ECOG) status of 0 or 1 |
||
| 3778 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 3 |
||
| 3779 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3780 | Eastern Cooperative Oncology Practice (Eastern Cooperative Oncology Group [ECOG]) score of 3 or below |
||
| 3781 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. |
||
| 3782 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of ?1 |
||
| 3783 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3784 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3785 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3786 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3787 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3788 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3789 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3790 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 3791 | At the time of recruitment, a Karnofsky performance status of 80 or above or an Eastern Cooperative Oncology Group (ECOG) score of 0 or 1 |
||
| 3792 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3793 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 3794 | Eastern Cooperative Oncology Group (ECOG) rating of >= 3 or Karnofsky performance status (KPS) < 60 as rated by the oncology provider |
||
| 3795 | Subjects with an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 3796 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, 2, or 3 |
||
| 3797 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3798 | Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 2 (symptomatic and in bed < 50% of the day) |
||
| 3799 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3800 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3801 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3802 | Eastern Cooperative Oncology Group (ECOG) performance score > 2 OR too ill to participate as judged by physician/in medical record |
||
| 3803 | Baseline Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 3804 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3805 | SCREENING PHASE: Eastern Cooperative Oncology Group performance status 0-2 |
||
| 3806 | INTERVENTION PHASE: Eastern Cooperative Oncology Group performance status 0-2 |
||
| 3807 | PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3808 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (within 90 days of enrollment) |
||
| 3809 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3810 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3811 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 3812 | Patients who have an Eastern Cooperative Oncology Group (ECOG) performance status score greater than 2 at time of recruitment |
||
| 3813 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 – 2 |
||
| 3814 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3815 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3816 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3817 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3818 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (at the time the subject signs their first informed consent form); |
||
| 3819 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3820 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 3821 | Easter Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3822 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 or less. |
||
| 3823 | Eastern Cooperative Oncology Group (ECOG) Performance status score of 0 to 1 |
||
| 3824 | Eastern Cooperative Oncology Group (ECOG) Performance Status ? 2 |
||
| 3825 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2. |
||
| 3826 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3827 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3828 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3829 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3830 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3831 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3832 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 1 |
||
| 3833 | Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status of 0-2 |
||
| 3834 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (Karnofsky >= 70%) |
||
| 3835 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2; |
||
| 3836 | Participants must have Eastern Cooperative Oncology Group (ECOG) performance status 0-2 (Karnofsky performance status of 50% or greater) |
||
| 3837 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3838 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3839 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3840 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 3841 | Participant must have an Eastern Cooperative Oncology Group (ECOG) Performance status of: 0 - 1 (dose escalation cohorts) or 0 - 2 (expansion cohorts) |
||
| 3842 | Eastern Cooperative Oncology Group performance status 0 or 1 |
||
| 3843 | Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3844 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3845 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3846 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3847 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3848 | No Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status requirements |
||
| 3849 | Karnofsky performance status (KPS) >= 50 or Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3850 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 3851 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3852 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3853 | Eastern Cooperative Oncology Group (ECOG) =< 1 |
||
| 3854 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status =< 2 or Karnofsky performance scale >= 60% |
||
| 3855 | Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3856 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3857 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3858 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3859 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3860 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or less |
||
| 3861 | Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) performance status of 0-2 |
||
| 3862 | Eastern Cooperative Oncology Group performance status of 0 or 1 as assessed within 21 days prior to randomization. |
||
| 3863 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3864 | Eastern Cooperative Oncology Group (ECOG) of 4 and life expectancy =< 2 weeks |
||
| 3865 | Patients with an Eastern Cooperative Oncology performance status of 0 or 1 |
||
| 3866 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3867 | The patient has an Eastern Cooperative Oncology Group (ECOG) performance status of grade 0 - 2 |
||
| 3868 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 3869 | Performance status 0 to 3 (Eastern Cooperative Oncology Group [ECOG] scale) |
||
| 3870 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3871 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3872 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 at Screening or by the day chemotherapy is initiated |
||
| 3873 | Patients will not be evaluated based on Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status (KPS) |
||
| 3874 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3875 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 |
||
| 3876 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3877 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 3878 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3879 | ECOG (Eastern Cooperative Oncology Group) scale performance status 0-3 |
||
| 3880 | Eastern Cooperative Oncology Group (ECOG) performance status 0-3 |
||
| 3881 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1 |
||
| 3882 | Eastern Cooperative Oncology Group (ECOG) performance status 2 or better |
||
| 3883 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 3884 | Have a World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance score =< 2 and life expectancy > 6 months |
||
| 3885 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3886 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3887 | Subjects with Eastern Cooperative Oncology Group (ECOG) performance status =< 3 (Karnofsky >= 30%) will be included |
||
| 3888 | Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1, or 2; use Lansky for patients =< 16 years of age |
||
| 3889 | Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3890 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3891 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3892 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2 or Karnofsky Status of 50 to 100. |
||
| 3893 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3894 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3895 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3896 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3897 | Eastern Cooperative Oncology Group (ECOG) performance status 0,1 |
||
| 3898 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3899 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3900 | Eastern Cooperative Oncology Group (ECOG) performance status must be 0 or 1 (Karnofsky >= 60%) |
||
| 3901 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3902 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3903 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3904 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status score of =< 2 |
||
| 3905 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3906 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3907 | Patients must have a Karnofsky performance status of 80% or higher or an Eastern Cooperative Oncology Group (ECOG) of 0-1 |
||
| 3908 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 |
||
| 3909 | Karnofsky performance score >= 60% or Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 3910 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3911 | Performance status of 0-2 according to the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 3912 | Eastern Cooperative Oncology Group (COG) performance status of 0-2 |
||
| 3913 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3914 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3915 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 or Karnofsky performance status (KPS) >= 60 |
||
| 3916 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3917 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 (fully active or restricted only in physically strenuous activity) |
||
| 3918 | Participants must have Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3919 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ?2 |
||
| 3920 | Eastern Cooperative Oncology Group performance status of 0-1. |
||
| 3921 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3922 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3923 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3924 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3925 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3926 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 3927 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3928 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3929 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 or Karnofsky >= 70% |
||
| 3930 | Participants must have an Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of 0-1 |
||
| 3931 | Eastern Cooperative Oncology Group (ECOG) 0 or 1 |
||
| 3932 | Have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2 |
||
| 3933 | Eastern Cooperative Oncology Group (ECOG) performance status >2 (See Appendix G) |
||
| 3934 | Patients with Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 3935 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3936 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3937 | Eastern Cooperative Oncology Group (ECOG) performance status 0- 2 |
||
| 3938 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3939 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3940 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3941 | Have an ECOG (EASTERN COOPERATIVE ONCOLOGY GROUP) performance status of 0, 1, or 2 |
||
| 3942 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3943 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3944 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1 |
||
| 3945 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 3946 | Eastern Cooperative Oncology Group (ECOG) 0, 1, or 2 |
||
| 3947 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 (Karnofsky >= 70%) |
||
| 3948 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 3949 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3950 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3951 | Must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3952 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 3953 | Subject has an Eastern Cooperative Oncology Group performance status of 0-2. |
||
| 3954 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 within 28 days prior to registration |
||
| 3955 | Eastern Cooperative Oncology Group (ECOG) score ? 2 |
||
| 3956 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 3957 | Eastern Cooperative Oncology Group (ECOG) performance status ? 1 at screening |
||
| 3958 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 3959 | Eastern Cooperative Oncology Group (ECOG) Performance Status of ? 2 |
||
| 3960 | Eastern Cooperative Oncology Group (ECOG) performance status 0–2 |
||
| 3961 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 (Karnofsky >= 70%) |
||
| 3962 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3963 | Eastern Cooperative Oncology Group (ECOG) performance status must be =< 2 (Karnofsky >= 60%) |
||
| 3964 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 1 within 28 days of registration |
||
| 3965 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky >= 70% |
||
| 3966 | The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3967 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3968 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 to =< 2 |
||
| 3969 | The patient has an Eastern Cooperative Oncology Group (ECOG) performance status of grade 0 – 2 |
||
| 3970 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 3971 | Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of 0-2 |
||
| 3972 | Patient must demonstrate an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 3973 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3974 | Subject must have Eastern Cooperative Oncology Group performance score =< 2 |
||
| 3975 | Eastern Cooperative Oncology Group (ECOG) performance status < 3 |
||
| 3976 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 3977 | Karnofsky performance status of ? 50 (or Eastern Cooperative Oncology Group (ECOG)/World Health Organization [WHO] equivalent) |
||
| 3978 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 1 |
||
| 3979 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3980 | Karnofsky performance status (KPS) ? 50 (Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] 0, 1, or 2) |
||
| 3981 | Karnofsky performance status (KPS) ? 50 (Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] 0, 1, or 2) |
||
| 3982 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level =< 1 |
||
| 3983 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3984 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3985 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 3986 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (or Karnofsky >= 60%) |
||
| 3987 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2 |
||
| 3988 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2 |
||
| 3989 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-1 |
||
| 3990 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3991 | Have a performance status of 0 - 2 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 3992 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 3993 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 3994 | Karnofsky performance status of 50 or greater (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3995 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/ World Health Organization [WHO] equivalent) |
||
| 3996 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 3997 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3998 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 3999 | The Eastern Cooperative Oncology Group (ECOG) performance status of 1 or better |
||
| 4000 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 4001 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 (Karnofsky >= 50%) |
||
| 4002 | Have an ECOG (Eastern Cooperative Oncology Group) performance status of 0-1 |
||
| 4003 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4004 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4005 | Karnofsky performance status of >= 50 (Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4006 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4007 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4008 | The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 or, based on judgment of the treating medical oncologist, can tolerate imaging and at least 6 months of ET |
||
| 4009 | Karnofsky performance status or Lansky play scale status of >= 60 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4010 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 4011 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4012 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 4013 | Any performance status on the Eastern Cooperative Oncology Group (ECOG) |
||
| 4014 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4015 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4016 | Eastern Cooperative Oncology Group (ECOG) performance status < 2 (Karnofsky > 60%) |
||
| 4017 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4018 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4019 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 4020 | Eastern Cooperative Oncology Group (ECOG) performance status =< 3 (Karnofsky performance status [KPS] >= 30) |
||
| 4021 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 1 within 14 days prior to being registered for protocol |
||
| 4022 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 1 |
||
| 4023 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4024 | Adequate performance status, Eastern Cooperative Oncology Group (ECOG) 0, 1, 2 |
||
| 4025 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4026 | Karnofsky performance status (KPS) >= 70 or Eastern Cooperative Oncology Group (ECOG) = 2 |
||
| 4027 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4028 | Karnofsky performance status or Lansky Play Scale status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4029 | Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed, but patients will need to be sufficiently healthy to tolerate all study procedures |
||
| 4030 | Eastern Cooperative Oncology Group (ECOG) performance status of <= 2 |
||
| 4031 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4032 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 4033 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 4034 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 1 |
||
| 4035 | AIM 3: Participants must be Eastern Cooperative Oncology Group (ECOG) status 0-3 |
||
| 4036 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 70%) |
||
| 4037 | Patient must have Eastern Cooperative Oncology Group (ECOG) status =< 2, as documented in patient’s medical record |
||
| 4038 | Eastern Cooperative Oncology Group (ECOG) performance status of 3 or less |
||
| 4039 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4040 | Karnofsky performance status of > 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4041 | Karnofsky performance status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4042 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4043 | Karnofsky performance status of > 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4044 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 1 |
||
| 4045 | Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, with no deterioration over the previous 2 weeks |
||
| 4046 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 2. |
||
| 4047 | Has an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 to 1 within 3 days prior to the first dose of study treatment. |
||
| 4048 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 4049 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 4050 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 (Part 1) or 0-2 (Part 2). |
||
| 4051 | Eastern Cooperative Oncology Group (ECOG) 0-1. |
||
| 4052 | Eastern Cooperative Oncology Group (ECOG) 0-1 |
||
| 4053 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 4054 | Eastern Cooperative Oncology Group (ECOG) performance status 0, 1, or 2 |
||
| 4055 | Has Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4056 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 4057 | Patients must have Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 4058 | An Eastern Cooperative Oncology Group (ECOG) performance status score of 0, 1, or 2 is required |
||
| 4059 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4060 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 4061 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4062 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4063 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 4064 | Has an Eastern Cooperative Oncology Group performance status of 0 to 1 |
||
| 4065 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 4066 | Eastern Cooperative Oncology Group (ECOG) performance status of >= 2. |
||
| 4067 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4068 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 4069 | Karnofsky performance status or Lansky Play Scale status of >= 50 (or Eastern Cooperative Oncology Group [ECOG]/World Health Organization [WHO] equivalent) |
||
| 4070 | Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 4071 | Karnofsky performance status of at least 70% or Eastern Cooperative Oncology Group (ECOG)/Zubrod level 1 |
||
| 4072 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4073 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4074 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2 |
||
| 4075 | Have an Eastern Cooperative Oncology Group (ECOG) score of 0-1 |
||
| 4076 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 to 2 |
||
| 4077 | Eastern Cooperative Oncology Group (ECOG) performance of 0-2 |
||
| 4078 | Easter Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 4079 | Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed |
||
| 4080 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4081 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4082 | The patient’s Eastern Cooperative Oncology Group (ECOG) performance status must be 0-2 |
||
| 4083 | Have a Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4084 | Subjects with an ECOG (Eastern Cooperative Oncology Group) performance status of Grade 0 - 2. |
||
| 4085 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4086 | Subject has an Eastern Cooperative Oncology Group (ECOG) status 0-2 |
||
| 4087 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4088 | Patients should be Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4089 | Eastern Cooperative Oncology Group (ECOG) performance status 0-1 |
||
| 4090 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4091 | Patient must have Eastern Cooperative Oncology Group (ECOG)/Zubrod status 0-2 |
||
| 4092 | Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status will not be used as an inclusion criterion |
||
| 4093 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2. |
||
| 4094 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4095 | Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1 |
||
| 4096 | Eastern Cooperative Oncology Group (ECOG) performance score of 0-2 |
||
| 4097 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 4098 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 4099 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 4100 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4101 | Eastern Cooperative Oncology Group (ECOG) performance status and/or other performance status 0, 1, or 2 or (Karnofsky performance status of 60 or above) |
||
| 4102 | Eastern Cooperative Oncology Group (ECOG) =< 2 |
||
| 4103 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of =< 2 |
||
| 4104 | Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 |
||
| 4105 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4106 | Eastern Cooperative Oncology Group (ECOG)/Zubrod/Southwestern Oncology Group (SWOG) performance status < 2 (Karnofsky performance status >= 70%) |
||
| 4107 | Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4108 | Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1 |
||
| 4109 | Eastern Cooperative Oncology Group (ECOG) status = 0 to 1 |
||
| 4110 | Eastern Co-operative Oncology Group (ECOG) performance status score of 0, 1, or 2 |
||
| 4111 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 4112 | Have a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scale |
||
| 4113 | Performance status Eastern Cooperative Oncology Group (ECOG) 0-2 |
||
| 4114 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4115 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. |
||
| 4116 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4117 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4118 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0 or 1 |
||
| 4119 | Have Eastern Cooperative Oncology Group (ECOG) performance status of ?2. |
||
| 4120 | Have a performance status of ?2 on the Eastern Cooperative Oncology Group (ECOG) scale. |
||
| 4121 | Eastern Cooperative Oncology Group [ECOG] performance status 0-2. |
||
| 4122 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4123 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4124 | Non-metastatic GI cancers are eligible only if the Eastern Cooperative Oncology Group (ECOG) performance status is 2, 3, or 4 at the time of consent (although patients with locally advanced [stage III] and inoperable pancreatic cancers are eligible regardless of their performance status) |
||
| 4125 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 4126 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 2 |
||
| 4127 | Eastern Cooperative Oncology Group (ECOG) performance score of 0 or 1. |
||
| 4128 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. |
||
| 4129 | Eastern Cooperative Oncology Group (ECOG) performance status of <=2. |
||
| 4130 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1. |
||
| 4131 | The patient has an Eastern Cooperative Oncology Group (ECOG) performance status ? 2 |
||
| 4132 | poor performance status, Eastern Cooperative Oncology Group (ECOG), of 2 |
||
| 4133 | Has an eastern cooperative oncology group (ECOG) performance status of 0-1. |
||
| 4134 | Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 4135 | Eastern Cooperative Oncology Group (ECOG) performance status ? 2. |
||
| 4136 | Performance status = 2 [Eastern Cooperative Oncology Group (ECOG)] |
||
| 4137 | Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 |
||
| 4138 | Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 |
||
| 4139 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4140 | The participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 4141 | The participant has an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2. |
||
| 4142 | Has an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. |
||
| 4143 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1 |
||
| 4144 | Eastern Cooperative Oncology Group performance status 0 or 1. |
||
| 4145 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 4146 | Women and men ?18 years of age with Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4147 | Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status of 0-2 (Karnofsky >= 60%) |
||
| 4148 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 |
||
| 4149 | Eastern Cooperative Oncology Group (ECOG) performance status of ? 2 |
||
| 4150 | Has eastern Cooperative Oncology Group (ECOG) performance status 0 or 1. |
||
| 4151 | Eastern Cooperative Oncology Group performance status of 0 or 1. |
||
| 4152 | Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, as assessed within 10 days prior to the start of study drug. |
||
| 4153 | Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (</=) 2 |
||
| 4154 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2 |
||
| 4155 | Eastern cooperative oncology group (ECOG) performance status of 0 or 1. |
||
| 4156 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 |
||
| 4157 | Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 |
||
| 4158 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 |
||
| 4159 | Participants must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0, 1, or 2. |
||
| 4160 | Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1 |
||
| 4161 | Eastern Cooperative Oncology Group (ECOG) performance status =< 2 (Karnofsky >= 60%) |
||
| 4162 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 4163 | Has a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) Performance Scale. |
||
| 4164 | Eastern Cooperative Oncology Group (ECOG) performance status 0-2. |
||
| 4165 | Have a performance status of =< 1 Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 4166 | Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 |
||
| 4167 | Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1 |
||
| 4168 | Have a performance status of 0 or 1 on the Eastern Cooperative Oncology Group (ECOG) performance scale |
||
| 4169 | Subjects must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 |
||
| 4170 | Eastern Cooperative Oncology Group (ECOG) performance status =< 1 |
||
| 4171 | Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ? 1 For Part B subjects only: |